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Proteolytic processing of the Amyloid Precursor Protein (APP) produces beta-amyloid
(Aβ) peptide fragments that accumulate in Alzheimer’s Disease (AD), but APP may also
regulate multiple aspects of neuronal development, albeit via mechanisms that are not
well understood. APP is amember of a family of transmembrane glycoproteins expressed
by all higher organisms, including two mammalian orthologs (APLP1 and APLP2) that
have complicated investigations into the specific activities of APP. By comparison, insects
express only a single APP-related protein (APP-Like, or APPL) that contains the same
protein interaction domains identified in APP. However, unlike its mammalian orthologs,
APPL is only expressed by neurons, greatly simplifying an analysis of its functions
in vivo. Like APP, APPL is processed by secretases to generate a similar array of
extracellular and intracellular cleavage fragments, as well as an Aβ-like fragment that can
induce neurotoxic responses in the brain. Exploiting the complementary advantages of
two insect models (Drosophila melanogaster andManduca sexta), we have investigated
the regulation of APPL trafficking and processing with respect to different aspects of
neuronal development. By comparing the behavior of endogenously expressed APPL
with fluorescently tagged versions of APPL and APP, we have shown that some full-length
protein is consistently trafficked into the most motile regions of developing neurons both
in vitro and in vivo. Concurrently, much of the holoprotein is rapidly processed into
N- and C-terminal fragments that undergo bi-directional transport within distinct vesicle
populations. Unexpectedly, we also discovered that APPL can be transiently sequestered
into an amphisome-like compartment in developing neurons, while manipulations
targeting APPL cleavage altered their motile behavior in cultured embryos. These
data suggest that multiple mechanisms restrict the bioavailability of the holoprotein
to regulate APPL-dependent responses within the nervous system. Lastly, targeted
expression of our double-tagged constructs (combined with time-lapse imaging)
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revealed that APP family proteins are subject to complex patterns of trafficking and
processing that vary dramatically between different neuronal subtypes. In combination,
our results provide a new perspective on how the regulation of APP family proteins
can be modulated to accommodate a variety of cell type-specific responses within the
embryonic and adult nervous system.
Keywords: APPL, M. sexta, D. melanogaster, secretase, migration, outgrowth, transport, amphisome
INTRODUCTION
The Amyloid Precursor Protein (APP) is the source of beta-
amyloid (Aβ) peptide fragments that accumulate in Alzheimer’s
disease (AD), but APP also has been implicated in multiple
aspects of neurogenesis and neuronal differentiation (Jung and
Herms, 2012; Sosa et al., 2013; Nicolas and Hassan, 2014).
APP is a member of an evolutionarily ancient family of type-
1 transmembrane glycoproteins found in all higher organisms,
typified by highly conserved extracellular and intracellular
protein interaction motifs that permit transmembrane signaling
(De Strooper and Annaert, 2000; Turner et al., 2003; van der
Kant and Goldstein, 2015). Numerous studies have demonstrated
that APP can function as a neuronal receptor, capable of binding
a variety of candidate ligands and transducing intracellular
responses that modulate cell adhesion, neuronal outgrowth, and
migration (Osterfield et al., 2008; Nikolaev et al., 2009; Rama
et al., 2012; Rice et al., 2013). In support of this model, APP can be
detected in the growing processes and focal adhesion complexes
of cultured cells, suggesting that APP signaling might regulate
the cytoskeletal dynamics required for neuronal outgrowth and
migration (Sabo et al., 2003; Wang et al., 2005; Young-Pearse
et al., 2007; Ramaker et al., 2013). In particular, members of the
APP family can function as unconventional G protein-coupled
receptors (Nishimoto et al., 1993; Giambarella et al., 1997;
Swanson et al., 2005), transducing responses to local cues via
the heterotrimeric G protein Goα to regulate neuronal guidance
(Brouillet et al., 1999; Ramaker et al., 2013, 2016). Conversely,
APP-Goα interactions have been found to decrease in patients
suffering from AD, suggesting that the dysregulation of normal
APP-Goα signaling might provoke neuropathological responses
(Shaked et al., 2009; Sola Vigo et al., 2009; Milosch et al.,
2014).
In addition to its potential role as a transmembrane receptor,
numerous functions have been ascribed to the cleavage products
of APP that are generated via proteolytic processing of the
Abbreviations: Aβ, beta-amyloid peptide derived from APP; AICD, APP
Intracellular Domain cleavage fragments of APP family proteins; APP, Amyloid
Precursor Protein; APP695, predominant isoform of APP in mammalian neurons
(695 amino acids); APLP1 and APLP2, APP-Like-Proteins 1 & 2 (additional APP
family members expressed in the mammalian brain); APPL, APP-Like, the insect
ortholog of human APP; BACE, β-secretase; CTF, C-terminal cleavage fragments
of APP family proteins; dAβ, Aβ-like peptide fragment derived from APPL; DIV,
Days in vitro; en, esophageal nerve of the foregut ENS in Manduca; ENS, enteric
nervous system; EP cells, neurons within the Enteric Plexus of the Manduca
ENS; HPF, hours post-fertilization; Kuz, Kuzbanian (ADAM 10 ortholog); PBS,
phosphate-buffered saline; PBST, PBS plus Tween-20; Psn, presenilin; p3, short
cleavage fragment generate by α- plus γ-secretase cleavage of APP; sAPP/sAPPL,
secreted ectodomain fragments of APP and APPL.
holoprotein by membrane-associated secretases (Figure 1). In
the amyloidogenic pathway, APP is initially cleaved by β-
secretase (BACE1) to generate a large soluble ectodomain
fragment (sAPPβ) and a shorter, membrane-bound C-terminal
fragment (β-CTF), which in turn is cleaved by γ-secretase
complexes to produce a small APP intracellular fragment
(AICD) and Aβ peptides (Gralle and Ferreira, 2007; Guo
et al., 2012). Alternatively, in the non-amyloidogenic pathway,
APP is initially cleaved by an α-secretase (typically ADAM10)
to generate sAPPα and α-CTF fragments, the latter being
further processed by γ-secretase to produce an identical
AICD and a p3 peptide that is rapidly degraded (Turner
et al., 2003; Haass et al., 2012). A plethora of biological
activities have been postulated for many of these fragments,
ranging from transcriptional regulation to synaptic remodeling
and neurodegenerative responses (Kimberly et al., 2005;
Kogel et al., 2012; Zhang et al., 2012; Nhan et al., 2015).
Nevertheless, authentic functions for particular APP cleavage
products within the developing nervous system remain under
debate.
Most models of APP-dependent signaling are based on
evidence that the full-length holoprotein can be transported
to peripheral regions of neurons before insertion into the
plasmamembrane, whereupon it undergoes rapid internalization
and/or cleavage (e.g., Schubert et al., 1991; Rice et al.,
2012; Octave et al., 2013; Sosa et al., 2013; Olsen et al.,
2014). In support of this model, rapid anterograde axonal
transport of APP has been clearly demonstrated in cell
culture (Koo et al., 1990; Seamster et al., 2012; Szpankowski
et al., 2012). In contrast, several recent reports have shown
that much of the holoprotein is actually processed into
different fragments that are assorted to distinct transport
vesicles before they exit the cell body (Muresan et al., 2009;
Villegas et al., 2014). Although initial studies argued that
axonally targeted APP must undergo retrograde transport
into the somatodendritic compartment before being processed
(Simons et al., 1995; Yamazaki et al., 1995; Kins et al.,
2006; Back et al., 2007), more recent work using stem cell-
derived neurons suggests the opposite pattern: namely, that a
substantial portion of full-length APP is initially inserted into
the somatodendritic compartment before being transcytosed and
processed in endosomal compartments. Only subsequently are
different fragments packaged into distinct vesicle populations
for axonal transport (Muresan et al., 2009; Muresan and
Ladescu Muresan, 2015). However, because most of these studies
were conducted using neuroblastoma cell lines or relied solely
on the overexpression of exogenous APP, the significance of
these different sorting and processing scenarios with respect
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FIGURE 1 | Insect APPL is cleaved by the same secretase classes that process APP. (A) Schematic image of the primary domains shared by human APP695
and APPL in Drosophila and Manduca. All APP family members contain similar extracellular domains (E1 and E2) that can interact with potential binding partners; a
highly conserved cytoplasmic domain (Go) that directly interacts with the heterotrimeric G protein Goα; and a C-terminal tyrosine-based sorting motif (Y) that interacts
with a variety of intracellular adapter and signaling molecules. Drosophila APPL contains larger non-conserved regions on either side of the E2 domain that increase
the overall size of the holoprotein, and an Aβ-like domain (dAβ) with neurotoxic activity when cleaved from the holoprotein; the biological activity of this domain in
Manduca APPL has not yet been verified. Similar to the cleavage products of APP695, processing of insect APPL by α- and β-secretases produces soluble
ectodomain fragments (sAPPLs) and short transmembrane C-terminal fragments (CTFs); subsequent cleavage of the CTFs by γ-secretase produces an APPL
intracellular domain (AICD), as well the dAβ peptide or a p3-like fragment (not shown). Labeled blue bars indicate the epitopes recognized by antibodies against APPL
or APP that were used in this study (as described in the Materials and Methods Section). (B,C) Western blots of lysates prepared from Manduca embryos (65 HPF),
5th instar CNS, Manduca GV-1 cells (which endogenously express APPL), and concentrated medium harvested from the GV-1 cultures. (B) Immunoblotting with
anti-cAPPL detects both the mature (black arrow) and immature (open arrow) full-length forms of APPL in all three lysates but not in GV-1 cell medium; a larger band
(∼165 kDa; open arrowhead) detected in mid-stage embryos might represent an additional post-translational modification that is developmentally regulated (as
previously reported; Swanson et al., 2005). (C) Immunoblotting with anti-nAPPL detects the same mature (black arrow) and immature (open arrow) full-length forms of
APPL, plus cleaved ectodomain fragments (sAPPLs) that are also present in GV-1 medium (black arrowhead). The relative intensity of this ectodomain band reflects
the rapid processing of full-length APPL; sAPPL produced by α- vs. β-secretases were not distinguished in this blot. (D,E) Cross-immunoprecipitation of Manduca
embryonic lysates with N- and C-terminal-specific antibodies against APPL. (D) Embryonic lysate (input) that was immunoprecipitated with anti-cAPPL (IP) and
immunoblotted with anti-nAPPL. (E) Embryonic lysate (input) that was immunoprecipitated with anti-nAPPL (IP) and immunoblotted with anti-cAPPL; both antibodies
recognize mature (black arrow) and immature (open arrow) forms of full-length APPL. (F) Western blot of Manduca embryo lysate (lower portion) labeled with
anti-cAPPL reveals two CTFs (black arrows) and a candidate AICD fragment (open arrowhead). (G) Western blot of Manduca embryo lysates treated with different
secretase inhibitors; in this shorter exposure (compared to F), neither CTF was detected (black arrows). In lysates of embryos treated with a γ–secretase inhibitor
(Continued)
Frontiers in Molecular Neuroscience | www.frontiersin.org 3 November 2016 | Volume 9 | Article 130
Ramaker et al. Developmental Regulation of APP Dynamics
FIGURE 1 | Continued
(lane 2), both CTFs were readily detected. Treatment with a combination of α- plus γ-secretase inhibitors reduced the relative abundance of the upper CTF band,
whereas treatment with β- plus γ-secretase inhibitors reduced the lower CTF band. Separate band labeled with “Act” indicates anti-actin (∼42 kDa) as a loading
control. (H) Quantification of CTF abundance in western blots of embryonic lysates (as illustrated in G). Treatment with α- plus γ-secretase inhibitors caused a
significant decrease in α-CTF levels (**p = 0.0002) and a more moderate increase in β-CTF levels (*p = 0.041). Treatment with β- plus γ-secretase inhibitors caused a
significant reduction in β-CTF (*p = 0.041) but did not affect α-CTF levels (p = 0.101). Relative intensities were normalized against γ-secretase-treated lysates in each
immunoblot. N ≥ 10 for each group; histograms show means ± SEM. Statistical comparisons were performed using one-way ANOVA followed by pairwise Student’s
two-tailed t-tests with the Bonferroni correction to obtain reported p-values. (I) Western blots of head lysates from flies expressing additional APPL in the eye
(GMR-GAL4; UAS-Appl), immunoblotted with anti-cAPPL. Lane 1, both α- and β-CTFs (arrows) could be readily detected in GMR>Appl flies. Lane 2, expressing
additional Drosophila Presenilin in this line (via UAS-dPsn) reduced α- and β-CTFs (β-CTF was no longer detectable at this exposure). Lane 3, expressing additional
dPsn plus Drosophila BACE (via UAS-dPsn + UAS-dBACE) preferentially reduced α-CTF levels (β-CTF was still detectable, compared to lane 2). Lane 4, expressing
additional Kuzbanian in this line (via UAS-Kuz) caused a marked increase in α-CTF and a corresponding reduction in β-CTF levels. (J) Western blots of head lysates
from flies carrying the eye-specific promoter construct GAL4-GMR, immunoblotted with anti-cAPPL. Lane 1, in flies overexpressing APPL (via UAS-Appl), both α- and
β-CTFs (arrows) could be readily detected (as in panel I, lane 1). Lane 2, in GMR-GAL4 control flies, only the α-CTF band was faintly detected at this exposure. Lane 3,
both CTFs were reduced in flies lacking one copy of the α-secretase Kuzbanian (kuz/+). Lane 4, co-expressing additional APPL and dBACE caused a preferential
increase in β-CTF levels. Separate bands in (I,J) labeled with “Tub” show anti-tubulin (∼55 kDa) as a loading control.
to APP-dependent functions in the nervous system remained
unclear.
Investigations into the normal roles of APP in mammalian
systems have been complicated by the discovery of two closely
related family members (APP-Like Protein 1 and 2; or APLP1
and APLP2) that share partially overlapping activities (Turner
et al., 2003; Shariati and De Strooper, 2013). In contrast, insects
express a single APP ortholog (APP-like, or APPL) that shares
all of the canonical features of human APP695 (the predominant
neuronal isoform), including highly conserved extracellular and
intracellular domains that interact with similar classes of ligands
and signaling proteins (Luo et al., 1990; Torroja et al., 1999;
Ashley et al., 2005; Swanson et al., 2005). Like APP, APPL
is subject to proteolytic processing by α, β, and γ-secretases
that generate an analogous spectrum of cleavage fragments,
including sAPPs, CTFs, AICDs, and an Aβ-like peptide (Luo
et al., 1995; Greeve et al., 2004; Carmine-Simmen et al., 2009;
Poeck et al., 2012). Also like mammalian APP, APPL plays
important roles in the developing nervous system, participating
in the control of neuronal migration and synaptic plasticity
(Torroja et al., 1999; Ashley et al., 2005; Ramaker et al., 2013;
Soldano et al., 2013; Bourdet et al., 2015). Notably, studies
in Drosophila have shown that defects caused by the loss of
APPL can be rescued by the expression of human APP695 (Luo
et al., 1992; Wentzell et al., 2012), indicating that these proteins
are both structurally and functionally homologous. However,
unlike mammalian APP (which is expressed by many cell types),
APPL is exclusively expressed in neurons, greatly simplifying
an analysis of its biological functions in vivo. Accordingly, we
have exploited the complementary strengths of two different
insect models (Manduca and Drosophila) to investigate the
developmental regulation of APPL trafficking and processing
within both the developing and adult nervous system. Using a
combination of in vitro and in vivo culture preparations, we
have also examined how dynamic changes in the distribution
of APPL and its cleavage products relate to the motile behavior
of developing neurons, and whether altering APPL processing






These studies were conducted using insect model systems that are
exempt from animal research protocols. Synchronous groups of
embryos of both sexes were obtained from an in-house colony of
Manduca sexta and staged using published markers (Copenhaver
and Taghert, 1989a,b). Embryos reared at 25◦C complete their
development in 100 h, so that 1 h post-fertilization (HPF) is
equivalent to 1% of development. Staged Manduca embryos
(50 per group; dissected at 65 HPF) were collected on dry ice,
homogenized in 1% Triton lysis buffer (1% Triton X-100, 150
mM NaCl, 50 mM Tris, pH 8) or 1% NP40 lysis buffer (150
mM NaCl, 50 mM Tris, pH 8), and the lysates were clarified by
centrifugation at 16,000 rpm for 10 min (Swanson et al., 2005).
Soluble proteins were then separated on 10% or 4–12% Criterion
polyacrylamide gels (Bio-Rad), transferred to nitrocellulose, and
immunoblotted with antibodies diluted in Tris-buffered saline
plus 0.1% Tween-20 (Polysorbate) and 5% Carnation dry milk.
The immunoblots were then incubated overnight at 4
◦
C with
anti-nAPPL (1:5000) or anti-cAPPL (1:2500), diluted in Tris-
buffered saline plus 0.1% Tween-20 (Polysorbate) and 5% dry
milk. Secondary antibodies coupled to Horseradish Peroxidase
(HRP; from Jackson ImmunoResearch) were then applied to the
blots at 1:10K and detected using standard chemiluminescent
protocols (with either West Pico or West Femto substrates;
Thermo Fisher). To detect CTF fragments in fly lysates, 15 heads
per genotype were homogenized in sample buffer. The lysates
were then loaded on 4–12% gradient gels and analyzed with our
published methods (Tschape et al., 2002). For labeling tagged
APP and APPL from transgenic Drosophila lines, western blots
were stained with anti-GFP (Santa Cruz Biotechnologies SC-
8334, 1:1000); anti-DsRed (Clontech # 632393; 1:100); and anti-
human APP (clone 22C11; 1:100). Antibodies against tubulin
(Developmental Studies Hybridoma Bank #E7; deposited by
Michael Klymkowsky) and actin (Sigma Aldrich # A2228) were
used to label these proteins as loading controls.
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For a cross-immunoprecipitation analysis of endogenous
APPL inManduca, supernatants of lysed embryos were prepared
as described above. After centrifugation, the supernatants were
transferred to Eppendorf tubes, pre-cleared with Protein
A/G beads (Santa Cruz Biotechnology), and incubated
with either anti-cAPPL or anti-nAPPL for 1–3 h at room
temperature. The samples were then incubated with pre-washed
beads for 1 h, and the bead-bound antibody complexes were
pelleted by centrifugation. After washing in chilled lysis buffer,
immunoprecipitated proteins were eluted by boiling in SDS
sample buffer for 1 min. The samples were then separated on
10% Criterion polyacrylamide gels, transferred to nitrocellulose,
and immunoblotted with the complementary anti-APPL
antibody: samples immunoprecipitated with antibodies against
the N-terminal domain of APPL were immunoblotted with
anti-cAPPL; samples immunoprecipitated antibodies against
the C-terminal domain were immunoblotted with anti-nAPPL.
In some experiments, we also used rabbit-anti-cAPP (Sigma-
Aldrich #A8717) and a custom rabbit-anti-APP antibody (C20),
generated against a conserved epitope within the cytoplasmic
domain of APP (Hare, 2001); both antibodies recognized the
same APPL fragments detected by our cAPPL antibody. As an
additional control, we used rabbit anti-nAPPL-EX, generated
against the sequence EDDDYTDADDSAWPRPES within
Manduca APPL (Swanson et al., 2005). Antibody detection was
performed as described above.
Whole-Mount Immunolabeling of Staged
Manduca Embryos
Staged embryos were dissected in defined saline (140 mM
NaCl, 5 mM KCl, 28 mM glucose, 40mM CaCl2, and 5mM
HEPES, pH 7.4) to expose the enteric nervous system (ENS),
as previously described (Horgan et al., 1995; Ramaker et al.,
2013). Alternatively, the embryonic gut was removed to expose
the developing central nervous system (CNS) before subsequent
processing (Swanson et al., 2005). Preparations were fixed in 4%
paraformaldehyde (PFA; Sigma/Aldrich) in phosphate-buffered
saline (PBS) for 1 h at room temperature, rinsed in PBS plus
0.1% Triton X-100 (PBST), and incubated for 1 h in blocking
solution (10% normal horse serum plus 0.1% sodium azide in
PBST). For some antibodies, we also fixed embryos for 1 h in
either Bouin’s fixative (formalin/aqueous saturated picric acid,
3:1; plus 5% glacial acetic acid); Zamboni’s fixative (2% PFA plus
15% aqueous saturated picric acid in sodium phosphate buffer;
pH 7.3); or Glyo-Fixx (Thermo-Fisher).
Fixed embryos were then incubated in antibodies diluted
in blocking solution for either 1 h at room temperature or
overnight at 4◦C. The following primary antibodies against
APPL and APP were used in this analysis: chicken anti-cAPPL
(1:2500), generated against the sequence YENPTYKYFEVKE
within the cytoplasmic domain of Manduca APPL (Swanson
et al., 2005); rabbit anti-nAPPL (#21506; 1:5000), generated
against a fusion protein derived from the E1 region of Manduca
APPL (AA 1–197; Ramaker et al., 2013); and rabbit-anti-
Drosophila APPL (antiserum 952; gift from Dr. Vivian Budnik),
generated against the ectodomain of Drosophila APPL (Torroja
et al., 1996, 1999). The specificity of these antibodies for
APPL has previously been validated (Swanson et al., 2005).
In some experiments, we also used the following antibodies
against the C-terminal domain shared by APPL and APP: anti-
cAPP (Sigma-Aldrich A8717), targeting amino acids 676–695 of
human APP695; and anti-APP668 (Sigma-Aldrich #SAB4300464),
targeting AA 666–670 of human APP695. Both antibodies
specifically recognize Manduca APPL, as previously reported
(Ramaker et al., 2013).
Embryos were counterstained with either anti-pan Fasciclin
II (Fas II; C3 mouse monoclonal; 1:20,000); anti-TM Fas II
(1:5000; which is specific for the transmembrane isoform of
Manduca Fas II); or anti-GPI-Fas II (1:5000; specific for the
glycosyl phosphatidylinositol-linked form of Fas II; Wright
et al., 1999; Wright and Copenhaver, 2000). Primary antibodies
were detected with secondary antibodies conjugated to Alexa
Fluor 488, 568, or 647 (Molecular Probes/Life Technologies;
1:1000) or conjugated to Cy3 and DyLight 549 (Jackson
ImmunoResearch; at 1:400), diluted in blocking solution.Whole-
mount immunolabeled preparations were mounted in Elvanol
(Banker and Goslin, 1998) and imaged with an Olympus
FluoView 300 laser scanning confocal head mounted on an
Olympus BX51 microscope (located in the Oregon Institute of
Occupational Health Sciences), or with an inverted Zeiss LSM710
confocal microscope (located in the Advanced Light Microscopy
Center of the Jungers Institute, OHSU). Maximum intensity
projections of flattened z-stack confocal images were generated
using MetaMorph and Fiji software.
Culture and Immunolabeling of Manduca
Neurons and GV1 Cells
Primary cultures of Manduca neurons were prepared following
the methods of Hayashi et al. (Hayashi and Hildebrand, 1990;
Hayashi and Levine, 1992). Briefly, ganglia fromManduca pupae
(P2–P4 stages) were enzymatically dissociated, and suspensions
of the dispersed neurons were plated in L-15-based culture
medium plus 10% fetal bovine serum (FBS) onto coverslips
(pre-coated with a mixture of Concanavalin A and laminin)
that had been affixed below 8 mm holes drilled into 35 mm
plastic dishes. After 1–14 days, neurons were fixed with 4% PFA,
permeabilized with PBST for 10 min, and immunolabeled with
anti-cAPPL and anti-nAPPL antibodies. Manduca GV1 cells are
an ectoderm-derived cell line (Lan et al., 1999; Hiruma and
Riddiford, 2004) that endogenously expresses APPL and other
neuronal proteins (Lan et al., 1999; Hiruma and Riddiford, 2004;
Swanson et al., 2005; Coate et al., 2009). GV1 cells were grown
on Lab-Tek tissue culture chamber slides (Nunc #177445) in
Grace’s complete medium plus 10% FBS to 50% confluence,
then fixed and immunolabeled, as previously reported (Coate
et al., 2009). Replicate cultures were co-immunolabeled with anti-
cAPPL plus each of the following antibodies against cytoplasmic
compartment markers, based on published evidence and epitope
predictions that these antibodies recognize homologous proteins
in Drosophila cells: rabbit-anti-Rab4 (Cell Signaling #2167,
1:500; and Abcam #ab87802, 1:200); rabbit-anti-Drosophila Rab5
(Abcam #ab31261, 1:500; Wang et al., 2014); rabbit-anti-Rab7
(Abcam #ab77993, 1:500) and rabbit-anti-dRab7 (1:1000; gift of
Dr. Patrick Dolph; 1:1000; Chinchore et al., 2009; Wang et al.,
2014); rabbit-anti-Rab9 (Abcam #ab179815, 1:200); rabbit-anti-
Rab10 (Abcam #ab113947, 1:500); goat-anti-Rab10 (Santa Cruz
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#sc-6564, 1:200); rabbit-anti-Rab11a (1:1000; gift of Dr. Don
Ready; Satoh et al., 2005); mouse-anti-Rab11 (BD Transduction
# 610657, 1:200; Wang et al., 2014); Rabbit-anti-Drosophila
LAMP1 (Abcam #ab30687, 1:500); rabbit-anti-Drosophila Lava
Lamp (gift of Dr. John Sisson, 1:250; Papoulas et al., 2005); rabbit
anti-Drosophila VPS4 (rabbit anti-Drosophila dVPS4, 1:100; gift
of Dr. Harald Stenmark; Rodahl et al., 2009); and rabbit-anti-
Evi (Evenless Interrupted, 1:400; gift of Dr. Vivian Budnik; Koles
et al., 2012). GV1 cells were also labeled with MitoTracker Green
FM and LysoTracker RedDND-99 (Life Technologies), following
the manufacturer’s protocols. Images of immunolabeled primary
neurons and GV1 cells were obtained as described above.
Secretase Inhibitor Assays of APPL
Processing in Manduca
StagedManduca embryos (∼62–63 HPF) were dissected dorsally
to expose the migratory EP cells within the developing ENS, as
previously described (Coate et al., 2008; Ramaker et al., 2013).
Embryos were then transferred to Eppendorf tubes containing
100 µl defined culture saline (140 mM NaCl, 5 mM KCl, 28
mM glucose, 5 mM HEPES, 4 mM CaCl2, pH 7.4; Horgan
and Copenhaver, 1998), plus 5–50 µM of each inhibitor or
vehicle control solutions. The following secretase inhibitors were
used in this analysis, based on published evidence that they
inhibit analogous secretases in Drosophila (Sinha et al., 1999;
Greeve et al., 2004; Groth et al., 2010): α-secretase inhibitors
GM6001 (Calbiochem) and GI 254023X (Tocris); β-secretase
inhibitors #171601 (Calbiochem) and #565788 (Calbiochem);
and γ-secretase inhibitor #565770 (DAPT). After incubation in
a 27
◦
C heat block for 2.5 h, the tissue was homogenized in 5
µl pre-warmed lysis buffer containing protease and phosphatase
inhibitors (4% SDS, 40% glycerol, 200 mM Tris-HCl, pH 6.7;
99◦C). Samples were subsequently centrifuged for 10 min at 16K
rpm to clarify the lysates. The supernatants were separated on
Bio-Rad 16.5% Tris-Tricine Criterion gels, and labeled in western
blots with anti-cAPPL antibodies, as described above.
Manduca Embryonic Culture and Migration
Assays
Staged Manduca embryos were isolated at ∼57 HPF, transferred
to Sylgard chambers containing defined saline, and opened
dorsally to expose the developing ENS. The EP cells were
then directly treated with secretase inhibitors or vehicle control
solutions. The preparations were allowed to develop for an
additional 5 h at 28◦C, then fixed and triple-immunolabeled with
anti-nAPPL, anti-cAPPL, and anti-Fas II antibodies (as described
above), using Alexa-Fluor conjugated secondary antibodies
for detection. To quantify the relative levels of membrane-
associated full-length APPL and Fas II (as an independent
control), 1.5-µm z-stack images (consisting of three sequential
0.5 µm confocal sections) were taken from the membrane
regions of leading EP cells that had migrated onto the mid-
dorsal band pathways. Three separate regions were imaged
in each preparation. The z-stacks were then compressed, and
fluorescent intensities within boxed regions of interest (ROI)
(spanning the plasma membrane of non-overlapping neurons)
were quantified independently for each channel using Fiji/ImageJ
software. Background fluorescence levels were determined from
equivalent z-stack images of adjacent interband muscle regions
(devoid of APPL and Fas II expression). The ratios of EP cell-
associated immunofluorescence vs. background levels were then
used to normalize the relative intensities of each fluorochrome
associated with the neuronal membranes. These values were
then used to compare relative levels of APPL and Fas II
expression between groups. All measurements were performed
under linear parameters. To analyze migration and axon
outgrowth distances in the culture preparations, the preparations
were re-immunolabeled with anti-Fas II (C3), followed by
immunodetection with the ABC method (Vector Laboratories),
using 3,3′-diaminobenzidine tetrahydrochloride (DAB) reacted
with H2O2 to label the neurons. As previously described, this
method produces unambiguous labeling of the neurons and
their processes in the developing ENS (Copenhaver and Taghert,
1989b; Wright et al., 1999). The extent of EP cell migration and
outgrowth was then analyzed and quantified from camera lucida
images of the preparations (Ramaker et al., 2013).
Drosophila Stocks and UAS Lines
To create fluorescently double-tagged constructs of APP family
proteins, we used cDNAs encoding APP695 (kindly provided
by R. Reifegerste, University Hamburg) and Drosophila APPL
(GH04413, obtained from Research Genetics, Huntsville), both
of which were cloned into the pUAST vector (Brand and
Perrimon, 1993). Plasmids containing the coding domains for
enhanced Green Fluorescent Protein (EGFP) andmonomeric red
fluorescent protein (mRFP; Clontech) were used to amplify the
sequences for the two fluorescent tags; mRFP was then cloned
in frame with the 3′ ends of both the APP695 and APPL coding
domains. To insert signal sequences upstream of the 5′ end of
the GFP sequence, we used overlapping primers against the signal
sequence from APP695 or APPL in sequential PCR reactions. The
resulting constructs (containing the appropriate signal sequence
plus EGFP) were then cloned 5′ to the APP695 and APPL coding
domains, from which the original signal sequences had been
deleted. The constructs were inserted into the fly genome by
standard P-element transformation (Spradling and Rubin, 1982).
GMR-GAL4, Ddc-GAL4, ChAT-GAL4, Tdc1-GAL4, elav-GAL4,
and UAS-kuz were provided by the Bloomington Stock Center;
Appl-GAL4 was provided by Dr. Laura Torroja (Universidad
Autónoma de Madrid), and the Appld fly line was provided
by Dr. Kalpana White (Brandeis University). UAS-dBACE and
UAS-APPL have been previously described (Carmine-Simmen
et al., 2009). Stocks were maintained and raised under standard
conditions.
Drosophila Primary Neuronal Cultures
Primary neuronal cell cultures from Drosophila white pupae
expressing double-tagged APP or APPL (under the control
of the different GAL4 drivers) were prepared as described by
Kraft et al. (1998). Briefly, neurons from prepupal brains were
dissociated via digestion with a collagenase/dispase solution and
triturated through a fire-polished glass pipette. Suspensions of
the dispersed neurons were plated in Schneider’s Insect Medium
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plus 10% FBS and 50 µg/ml insulin onto coverslips affixed
to drilled 35 mm plastic dishes (as described above). The
cultures were maintained for 1–8 days, and then either imaged
live on an inverted microscope or fixed and immunolabeled
(Wentzell et al., 2014). Primary neuronal cultures were fixed in
4% PFA for 5 min and immunolabeled following the protocol
described by Buchner et al. (in Ashburner, 1989). To enhance
the detection of fluorescently tagged APP695 and APPL in fixed
preparations, the neurons were double-stained with rabbit anti-
GFP (Santa Cruz Biotechnologies SC-8334, 1:1000) and mouse
anti-DsRed (Clontech # 632393; 1:500), followed with Cy2-
and Cy3-conjugated secondary antibodies (at a 1:1000 dilution;
Jackson ImmunoResearch). Preparations were then mounted in
Elvanol and imaged using an Olympus FluoView confocal 300
microscope.
For live-cell imaging experiments, measurements of
fluorescent vesicle movements were performed on cultured
neurons expressing double-tagged APP695 or APPL using a
Leica DM-IRBE microscope, equipped with a 63x Plan Apo
1.32 NA objective lens and a MicroMax Interline CCD camera
(Princeton Instruments). Images were taken every 2 s for 98 s,
and analyzed using the kymograph function in MetaMorph
(Molecular Devices). For each movie frame, the brightest
pixel within a 2 µm corridor along the axis of a neurite was
displayed at the corresponding location on a kymograph. The
fluorescence patterns for all 50 movie frames were then displayed
graphically as an adjacent series, whereby the x-axis of each
graph represented time and the y-axis represented distance along
the process.
Immunolabeling and Live Imaging of
Drosophila Brains
Live imaging of intact 3rd instar larvae expressing double-tagged
APP/APPL proteins in neurons was performed by immobilizing
the larvae in gelatin/glycerol mounting medium (Ashburner,
1989), and images were collected with a Zeiss Axioscope 2
microscope. To detect expression within the fly CNS, adult
brains were dissected as unfixed whole-mount preparations in
Drosophila Ringer’s solution and imaged by confocal microscopy.
To image the transport dynamics of vesicles within intact tissues,
brain-eye disc complexes from third instar larvae or brains from
adult flies were dissected and transferred to a small chamber
containing Ringer’s solution. Imaging was performed using a
Yokogawa CSU-10 spinning disc confocal head mounted on
a Nikon TE2000 inverted microscope, equipped with 60x/1.45
NA Plan Apo objective and illuminated with an Innova
70C Spectrum ion laser. Dual-color recordings were acquired
every 2 s by fast sequential imaging (500 ms exposure per
channel), captured with an Orca ER CCD camera (Hamamatsu
Instruments).
Statistical Methods
Relative levels of α- and β-CTF fragments were quantified from
western blots (Figures 1G,H), using our published methods
(Ramaker et al., 2013). Briefly, immunoblots were visualized
by chemiluminescence, and scanned TIFF images of the blots
were used to quantify relative pixel intensities within ROI
using Fiji. The values within each lane were then normalized
to intensity values for actin (for Figure 1G) and tubulin (for
Figures 1I,J), used as loading controls. One-way Analysis of
Variance (ANOVA) was performed to determine if mean values
differed significantly among any of the groups, followed by
pairwise Student’s two-tailed t-tests. To adjust for multiple
pairwise comparisons, the Bonferroni correction was applied to
obtain the reported p-values. To analyze vesicle distributions
containing APPL in the migratory EP cells (Figure 5C), confocal
images were collected from regions corresponding to trailing and
leading cells within each embryo.Maximum intensity projections
containing three optical sections (spanning a total of 0.9µm)
were converted to images in Fiji that contained only the overlap
in nAPPL and cAPPL signals. The images were then converted
to binary mode, and subjected to watershed segmentation. ROIs
encompassing individual EP cells were then selected to quantify
large perinuclear vesicles containing APPL, using the “analyze
particle” command. To normalize the accepted particles across
images, particle size was set as 1/100 of the average area for all
EP cells in that image. Circularity was set from 0.05 to 1, and
quantification was performed for each EP cell both as the number
of vesicles per cell and the percent area of large APPL-containing
vesicles based on total cell area. Both methods of analysis
produced similar results; accordingly, the number of vesicles per
EP cell was used for subsequent reporting purposes. Student’s
two-tailed t-tests were used to compare the average number of
vesicles in trailing vs. leading cells at each developmental stage.
At least three embryos were included at each stage, with a total of
10–20 EP cells averaged in each group.
To analyze fluorescent intensities in the EP cells by
quantitative immunofluorescence confocal microscopy
(Figure 8B), relative intensity values were calculated
independently for APPL and Fas II expression in each
experimental group (n = 10 per group), and statistical
differences between groups were calculated using unpaired
Student’s t-tests. One-way ANOVA was used to determine if
means differed among the four groups, followed by Student’s
two-tailed t-tests for pairwise comparisons. The Bonferroni
correction was applied to obtain reported p-values. For our
analysis of EP cell migration and outgrowth (Figure 8D), means
were calculated for each experimental group, normalized to
matched control embryos in each preparation (n = 10 per
condition). Statistical differences between groups were calculated
using one-way ANOVA, followed by unpaired Student’s t-
tests with the Bonferroni correction to obtain p-values. For
our analysis of vesicle movements in cultured Drosophila
neurons (Figure 11), at least 4 events per cell were analyzed
per genotype (n > 15 cells per genotype) in four independent
experiments.
RESULTS
Secretase-Dependent Cleavage of APPL
Resembles APP Processing
Previous work has shown that insect APPL shares the key
structural features of mammalian APP695 (Figure 1A), while
experiments using Drosophila have identified orthologs for
the three secretase classes associated with APP processing
(described below). Notably, secretase-dependent processing of
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APPL produces the same types of cleavage fragments as APP695
(Figure 1A), including soluble ectodomain fragments (sAPPLs),
membrane-bound CTFs, intracellular AICD fragments, and a
neurotoxic Aβ-like peptide (Luo et al., 1995; Fossgreen et al.,
1998; Greeve et al., 2004; Carmine-Simmen et al., 2009; Poeck
et al., 2012). To investigate the expression and processing of
endogenous APPL in the insect nervous system, we used a
panel of antibodies against different domains of Manduca APPL
(Swanson et al., 2005; Ramaker et al., 2013). In western blots
of proteins extracted from developing embryos, larval CNS,
and Manduca GV1 cells (which endogenously express APPL),
antibodies against both C-terminal APPL (Figure 1B) and N-
terminal APPL (Figure 1C) recognized the mature holoprotein
(135 kDa; black arrows) and a smaller band (∼115 kDa; open
arrows) that represents an immature, partially glycosylated
form. Anti-cAPPL antibodies also recognized a larger band at
∼165 kDa in embryonic lysates (open arrowhead), which might
represent an additional post-translational modification of APPL
that is developmentally regulated (Swanson et al., 2005). In
contrast, only anti-nAPPL antibodies labeled a 120 kDa band
(Figure 1C, black arrowhead) that was also detected in the
medium of cultured GV1 cells (last lane in blot). As previously
reported (Swanson et al., 2005), this band represents secreted
sAPPL fragments that are cleaved from full-length APPL.
To validate the identities of these bands, we performed cross-
immunoprecipitation experiments with Manduca embryonic
lysates, whereby proteins immunoprecipitated with either
anti-cAPPL or anti-nAPPL were immunoblotted with the
complementary antibody. As shown in Figures 1D,E, both
antibodies specifically recognized the mature and immature
forms of the holoprotein (black and open arrows, respectively),
whereas the cleaved sAPPL ectodomain fragments (lacking
cytoplasmic domains) were not cross-immunoprecipitated.
Similar results were obtained when we used other antibodies
recognizing different domains of APPL (as indicated in
Figure 1A), including anti-Ex-APPL and anti-Drosophila APPL
952 (against N-terminal epitopes). As shown in Figure 1F,
anti-cAPPL also labeled a pair of candidate CTF fragments
(11–15 kDa; black arrows) and a smaller fragment (∼8 kDa; open
arrow) that represents a candidate AICD fragment. Several anti-
APP antibodies targeting C-terminal epitopes that are conserved
in APPL (illustrated in Figure 1) also recognized one or both
of the CTF bands (not shown), providing additional evidence
that these fragments are authentic cleavage products of APPL.
Knocking down APPL expression in GV1 cells with morpholino
antisense oligonucleotides eliminated labeling of all of these
bands (Ramaker et al., 2013, 2016), indicating that they are
authentic cleavage fragments of the holoprotein.
These results indicate that Manduca APPL is subject to a
similar pattern of secretase processing that has been documented
for human APP695. To explore the identities of the CTF-like
fragments detected in Manduca lysates, we treated cultured
embryos with inhibitors known to block the activity of both
insect and mammalian secretases, and then examined the relative
abundance of the two bands in western blots labeled with anti-
cAPPL (Figure 1G). Using a relatively short exposure time that
did not detect the CTFs in control embryos (lane 1), we found
that treatment with a γ-secretase inhibitor (DAPT) resulted in
a strong elevation in both CTFs (Figure 1G, lane 2), suggesting
that endogenously expressed APPL is normally subject to rapid
processing (similar to APP; Gralle and Ferreira, 2007; Hare,
2001). Treating embryos with a combination of inhibitors
against α- and γ-secretases (Figure 1G, lane 3) resulted in
a significant reduction in relative abundance of the larger
fragment (the candidate α-CTF of APPL), accompanied by a
corresponding increase in the smaller fragment (the candidate
β-CTF). Conversely, treatment with a combination of β- and
γ-secretase inhibitors selectively reduced the levels of the
smaller fragment (Figure 1G, lanes 4). The lower immunoblot in
Figure 1Gwas labeled with anti-actin (Act;∼42 kDa) as a loading
control. Quantification of these results are shown in Figure 1H
(∗p= 0.041; ∗∗p= 0.0002).
Genetic manipulations of APPL processing in Drosophila
produced complementary results (Figures 1I,J). Using the eye-
specific promoter construct GMR-GAL4, we found that inducing
the expression of an additional copy of full-length APPL (via
UAS-Appl) resulted in detectable levels of both α-CTFs and
β-CTFs (Figure 1I, lane 1). As expected, expressing additional
Drosophila Presenilin (via UAS-dPsn) reduced both α- and β-
CTF levels in these flies (lane 2), verifying that CTFs derived
from APPL are subject to secondary processing by γ-secretase
activity. In contrast, expressing additional Drosophila BACE plus
dPsn (via UAS-dBACE plus UAS-dPsn) preferentially reduced
α-CTF levels (lane 3), whereas overexpressing the α-secretase
Kuzbanian (via UAS-Kuz) caused a marked increase in α-CTF
levels, accompanied by the loss of β-CTF (lane 4). In a second
experiment, we again showed that expressing additional full-
length APPL (via GMR-GAL4) resulted in a marked increase
in both α-CTF and β-CTF levels (Figure 1J, lane 1), whereas
only the α-CTF band was faintly detectable at this exposure
in control flies (carrying GMR-GAL4; lane 2). In contrast,
eliminating one copy of Kuzbanian (kuz/+) moderately reduced
α-CTF levels in these flies (lane 3, upper band), although
paradoxically, β-CTF levels were also reduced (lower band).
This result may reflect the fact that blocking APPL cleavage by
α-secretases also prolongs the retention of the holoprotein in
the plasma membrane (described below), which may interfere
with its subsequent trafficking into compartments required
for β-secretase processing (Nalivaeva and Turner, 2013). In
contrast, expressing an additional copy of dBACE caused a
marked increase in β-CTF levels, as expected (lane 4). The lower
immunoblots in Figures 1I,J was labeled with anti-tubulin (Tub;
∼55 kDa) as a loading control.
APPL Trafficking and Processing
Corresponds to the Motile Behavior of
Cultured Neurons
To explore how APP family proteins are developmentally
regulated, we first examined the endogenous distributions of
APPL in isolated Manduca neurons grown in culture. In newly
plated neurons that had commenced their initial outgrowth (day
1 in vitro; DIV), we could readily detect membrane-associated
APPL within the most distal regions of their growing
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processes (Figure 2A; arrows). Note that anti-nAPPL and anti-
cAPPL immunolabeling is presented as gray scale images for
the individual channels but shown in green and magenta
(respectively) in themerged images, whereby co-immunolabeling
appears white (right hand column). However, we also found
that a substantial portion of full-length APPL localized to a
distinct population of large cytoplasmic vesicles (Figures 2A,B,
white arrowheads), which were intermingled with numerous
smaller vesicles containing either N-terminal (Figure 2B, green
arrowheads) or C-terminal fragments (Figure 2B, magenta
arrowheads). This pattern persisted throughout subsequent
periods of neurite outgrowth (3–5 DIV): some full-length APPL
was concentrated at the distal tips of exploratory growth cones
(Figure 2C, arrows), while more of the holoprotein and its
fragments localized to different vesicle populations. In general,
N-terminal fragments were relatively more abundant in the
neuronal somata while C-terminal fragments were enriched
in their growing neurites, although we could detect vesicles
containing both fragments throughout the neurons.
By comparison, neurons that were no longer actively growing
(at 8–10 DIV) exhibited a markedly different pattern of APPL
immunoreactivity. Although, full-length APPL was still readily
apparent in large cytoplasmic vesicles within their cell bodies,
the holoprotein was greatly reduced in their distal processes
(Figure 2D; open arrows), while smaller vesicles containing
C-terminal fragments remained abundant throughout their
neurites. This distinction was even more apparent in neurons
undergoing retraction (12–14 DIV), in which the holoprotein
was largely absent from their most distal regions (Figure 2E;
open arrowheads), leaving only a diffuse distribution of cAPPL
immunolabeling in the neuronal processes (shown in magenta).
These results indicate that in neurons undergoing active
outgrowth, full-length APPL is rapidly transported into their
most motile regions but then is rapidly cleaved, whereas in
non-motile or retracting neurons, the holoprotein accumulates
predominantly in large cytoplasmic vesicles.
APPL Trafficking and Processing
Corresponds to the Motile Behavior of
Migratory Neurons In vivo
Previously, we showed that APPL expression is strongly
upregulated by migratory neurons that populate the Enteric
Nervous System (ENS; Swanson et al., 2005). During the
formation of the ENS (Figure 3), a population of ∼300 neurons
(EP cells) undergoes a stereotyped sequence of migration to form
a branching nerve plexus called the Enteric Plexus, which spans
the foregut-midgut boundary (FG/MG). After emerging from
a neurogenic placode (Copenhaver and Taghert, 1990), the EP
cells initially spread bilaterally around the circumference of the
foregut (from 40 to 55 HPF; Figure 3A), during which subsets
of neurons align with one of eight equivalent muscle bands (“b”)
that coalesce on the midgut surface. The neurons then abruptly
commence a phase of active migration onto these band pathways
(from 55 to 65 HPF; Figure 3B), traveling in a chain-like manner
along each band while avoiding adjacent interband regions (“ib”).
Subsequently, the neurons transition from migration to axon
FIGURE 2 | APPL trafficking and processing in cultured Manduca
neurons corresponds to their stage of outgrowth. Neurons harvested
from the CNS of fifth instar larvae were grown as dispersed cultures on glass
coverslips for 1–14 days in vitro, then fixed and immunolabeled with a
combination of anti-nAPPL (green) and anti-cAPPL (magenta) antibodies.
Anti-nAPPL and anti-cAPPL are shown individually as gray scale images but
are shown in green and magenta (respectively) in the merged images, whereby
co-immunolabeling appears white (right hand column). (A) By Day 1, neurons
had begun to extend numerous processes with exploratory growth cones
(arrows); full-length APPL (white immunolabeling) accumulated in the leading
filopodia, while C-terminal fragments (magenta arrowheads) were relatively
more abundant throughout the growing neurites and N-terminal fragments
(green arrowheads) were enriched in the cell bodies. APPL holoprotein also
accumulated in a population of large perinuclear cytoplasmic vesicles (white
arrowhead). (B) Higher magnification view of the neuron shown in (A);
numerous small vesicles containing only N-terminal fragments (green
arrowheads) or C-terminal fragments (magenta arrowhead) were interspersed
among the larger vesicles containing the holoprotein (white arrowheads). (C)
By day 3, many neurons had extended primary neurites with enlarged growth
cones; as is apparent in the merged image, APPL holoprotein (white
immunolabeling) continued to be enriched at the leading edges of the growth
cones and in some filopodia (arrows), while numerous smaller vesicles
containing either N-terminal or C-terminal fragments were distributed
throughout the neuronal somata and processes. (D) By day 8, most neurons
were no longer undergoing active outgrowth. Full-length APPL was still
abundant within vesicles in their somata (white immunolabeling in the merged
image) but was no longer concentrated in the distal tips of their processes
(open arrows). By comparison, vesicles containing C-terminal fragments
(Continued)
Frontiers in Molecular Neuroscience | www.frontiersin.org 9 November 2016 | Volume 9 | Article 130
Ramaker et al. Developmental Regulation of APP Dynamics
FIGURE 2 | Continued
(magenta arrowheads) were diffusely distributed throughout the neurons and
their processes, while N-terminal fragments (green arrowheads) remained
relatively more abundant in the somata. (E) By 12 days, most neurons were
either undergoing retraction (open arrows) or initiating degeneration (not
shown). APPL holoprotein was almost completely absent from their distal
processes, as were vesicles containing N-terminal fragments, whereas
vesicles containing C-terminal fragments (magenta) could still be detected
throughout the neurons. These results suggest that full-length APPL is
selectively transported to the distal tips of developing neurons during periods
of active outgrowth. Scale bar = 2 µm in (B); 10µm in all other panels.
elongation (at ∼65 HPF, Figure 3C), during which they extend
fasciculated bundles of axons posteriorly along the muscle bands.
Only after axon outgrowth is complete do the EP cells elaborate
terminal branches onto the adjacent interband musculature
(from 80 to 100 HPF), providing a diffuse innervation to the
midgut (Copenhaver and Taghert, 1989a,b). Accordingly, we
used this preparation to examine the developmental regulation of
APPL in motile neurons within the developing nervous system.
For our initial analysis, we used a combination of antibodies
specific to the N- and C-terminal domains of APPL to distinguish
the holoprotein from its fragments in immunolabeled embryos.
Intriguingly, we observed a similar sequence of endogenous
APPL trafficking and processing in the migratory EP cells as seen
in cultured neurons, corresponding to their motile behavior. In
pre-migratory neurons (55 HPF), we could readily detect full-
length APPL in their leading processes contacting their future
band pathways (Figure 3D, arrowheads), and subsequently in the
growth cones of their axons extending posteriorly along the band
pathways (Figures 3E,F, arrowheads). Figure 4 shows magnified
views of how full-length APPL continues to be concentrated
within the leading processes of the EP cells throughout their
migration and subsequent axon outgrowth. As in our primary
neuronal cultures, we also consistently detected abundant
populations of smaller vesicles labeled with anti-nAPPL, anti-
cAPPL, or both domains (highlighted in Figure 4D). Once again,
vesicles containing only N-terminal epitopes (green) tended
to be smaller in diameter and were more abundant in the
cell bodies, while larger vesicles containing only C-terminal
epitopes (magenta) were more abundant in their elongating
axons (Figure 3F). Also apparent at lower magnification were
hemocyte macrophages that labeled only with anti-nAPPL
antibodies (Figures 3D–F, “m”). In unpublished studies, we
have used proteomics methods and qRT-PCR assays to show
that these macrophages do not themselves express full-length
APPL; rather, they sequester cleaved sAPPL ectodomains both
in primary culture and in cultured embryos, indicating that they
scavenge fragments released by the developing neurons. Of note
is that we obtained similar results using different fixation and
permeabilization conditions (including 2–8% PFA, Bouin’s and
Zamboni’s fixatives), and with a variety of antibodies against
different N- and C-terminal epitopes within APPL.
However, as with our neuronal cultures, we also observed
that much of the holoprotein did not reside at the plasma
membrane, accumulating instead within large cytoplasmic
vesicles that co-immunolabeled with antibodies against both N-
and C-terminal APPL (visible as white vesicles in Figures 3, 4).
This vesicle class was particularly abundant in EP cells that had
not yet begun to migrate (Figure 4A, open arrows) but became
noticeably reduced in neurons undergoing active locomotion
(Figures 4A,B, arrows), coincident with the accumulation of the
holoprotein in their leading processes (Figure 4B, arrowheads).
This developmentally regulated redistribution of APPL was
more apparent at higher magnification (Figure 5). When we
compared the number of large vesicles (>100 nm) in migratory
EP cells vs. trailing/stationary neurons at progressive stages
of development, we found that the leading neurons on each
pathway (undergoing active locomotion) had significantly fewer
of these large vesicles (Figure 5B, 55–58 HPF) than in trailing
neurons that had not yet begun to migrate (Figure 5A, 55–58
HPF). Even after the neurons had transitioned from migration
to axon outgrowth (65 HPF), the relative abundance of these
vesicles remained low, while full-length APPL continued to
accumulate in the growth cones of their elongating axons
(Figure 4C, arrowheads). Quantification of large vesicles in
leading vs. trailing neurons at each developmental stage is
shown in Figure 5C (∗∗p = 0.002; ∗∗∗p = 0.001; ns = not
significant).
We detected a similar pattern of APPL fragments within
the developing CNS (Figure 6). In both segmental ganglia
(Figure 6A) and brain (Figures 6B,C), vesicles containing
only N-terminal APPL fragments (green) were considerably
more abundant in the neuronal somata (occupying cortical
regions of the CNS), while vesicles containing only C-terminal
fragments (magenta) were enriched within more central neuropil
regions and axon fascicles. Most neurons also contained
the larger class of cytoplasmic vesicles that labeled with
both N- and C-terminal antibodies, indicating the presence
of the holoprotein (Figure 6, white arrowheads). As in the
developing ENS, we routinely observed peripheral macrophages
associated with the surface of the CNS that labeled only
with anti-nAPPL antibodies (Figures 6A–C, “m”), due to their
sequestration of cleaved sAPPL fragments released from the
nervous system (unpublished observations). In addition, we
detected a distinct population of smaller cells in the CNS
(yellow arrowheads) that were also labeled with anti-nAPPL
but not anti-cAPPL. As discussed below, these cells might
represent an astrocyte-like population that also scavenges sAPPL
fragments or they may comprise a distinct neuronal subtype
that preferentially accumulates nAPPL cleavage products in their
somata.
APPL Localizes to an Amphisome-Like
Compartment in a Developmentally
Regulated Manner
To explore the identity of the large vesicles that accumulate
APPL, we initially used Manduca GV1 cells, which (as noted
above) endogenously express APPL. For this analysis, we used
a panel of antibodies against proteins associated with different
intracellular compartments that had been previously shown
to label the targeted proteins in Drosophila or that were
directed against evolutionarily conserved motifs. Surprisingly,
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FIGURE 3 | APPL expression is developmentally regulated by the migratory EP cells within the enteric nervous system (ENS) of Manduca. (A–C)
Schematic diagrams of EP cell migration, illustrating the progression of the motile neurons (blue) along the midgut muscle bands (orange). Black arrows indicate the
positions of the leading neurons on each band pathway. (A) Embryo at 55 HPF; at this stage, the EP cells form a packet of pre-migratory neurons that have spread
bilaterally around the circumference of the foregut, adjacent to the foregut-midgut boundary (FG/MG). Small groups of these neurons extend their leading processes
onto each of the eight coalescing muscle bands (“b”) on the midgut (only the four dorsal bands are shown). (B) By 60 HPF, small groups of EP cells have begun to
migrate and extend leading processes along the muscle bands while avoiding the adjacent interband regions (“ib”). (C) By 65 HPF, the EP cells have transitioned from
active migration to an extended period of outgrowth, during which they elongate fasciculated axons along each band pathway (beyond the field of view in C). Only
once axon outgrowth is complete (80 HPF) will the neurons extend terminal synaptic processes onto the interband regions (not shown). (D–F) Staged Manduca
embryos fileted to expose the developing ENS and immunolabeled with a combination of anti-nAPPL (green) and anti-cAPPL (magenta) antibodies. (A) Embryo at
55HPF (compare with A). APPL is robustly expressed by the EP cells but not the adjacent muscle cells of the foregut and midgut. Full-length APPL (white
immunolabeling) accumulates in the leading processes of neurons that have contacted adjacent muscle bands (arrowheads), and also in a population of large
cytoplasmic vesicles within the pre-migratory neurons. By comparison, C-terminal fragments (magenta) are relatively more abundant within fasciculated axons in the
anterior esophageal nerve of the foregut (“en”), while N-terminal fragments (green) are diffusely localized throughout the somata of the pre-migratory EP cells.
N-terminal fragments are also highly concentrated in peripheral macrophage hemocytes (“m”) that surveil the developing nervous system and sequester cleaved APPL
ectodomains (unpublished observations). (D) Embryo at 60 HPF (compare with B). EP cells that have migrated onto the muscle bands continue to exhibit robust levels
of APPL expression, with full-length APPL being concentrated in their leading processes and growth cones (arrowheads). At this stage, the leading neurons on each
pathway contain substantially fewer large cytoplasmic vesicles enriched with full-length APPL (white immunolabeling) than trailing/stationary neurons. (E) Embryo at 65
HPF (compare with C); at this stage, the EP cells transition from migration to axon outgrowth. Full-length APPL (white immunolabeling) continues to be concentrated
in their leading growth cones (arrowheads). C-terminal APPL fragments (magenta) are noticeably more abundant in their fasciculated axons, while N-terminal
fragments (green) are more apparent in their somata (as well as in the peripheral macrophages). Open arrows indicate small subsets of EP cells that occupy foregut
nerves between adjacent band pathways and that extend short processes onto the interband musculature. Scale bar = 30 µm.
although antibodies against Rab4, Rab5, Rab9, and Rab10
clearly labeled different vesicle populations in GV1 cells
(Supplementary Figure S1), none of these compartment markers
colocalized with the large vesicles containing APPL holoprotein.
Likewise, we detected little or no colocalization of APPL with
markers for Golgi (anti-Drosophila Lava lamp), mitochondria
(Mitotracker Green), lysosomes (anti-Lamp1 and Lysotracker
Red), or proteins associated with multivesicular bodies (VPS4)
and exosomes (Evi) (Supplementary Figure S1; and data not
shown). In contrast, multiple antibodies against both Rab7
and Rab11 strongly co-labeled APPL-positive vesicles in GV1
cells (Figures 7A,B), and this finding was recapitulated in the
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FIGURE 4 | Full-length APPL traffics into the leading growth cones and
elongating axons of the motile EP cells. (A–C) show the developing ENS
of fileted embryos at progressive stages of development,
double-immunolabeled with antibodies against nAPPL (green) and cAPPL
(magenta) epitopes. Arrowheads indicate leading growth cones/processes;
arrows indicate leading EP cell bodies. (A) 55 HPF: in EP cells that have begun
to migrate, full-length APPL (white immunolabeling) is concentrated in their
leading processes rather than their cell bodies. In contrast, trailing neurons
that have not begun to migrate (open arrowheads) exhibit numerous large
vesicles containing the holoprotein. (B) 58 HPF: in EP cells undergoing active
migration (arrows), full-length APPL continues to be concentrated in their
leading processes (arrowheads), with relatively few large vesicles in their
somata. (C) 65 HPF: once the EP cells have transitioned to axon outgrowth,
full-length APPL continues to accumulate in their growth cones that extend
posteriorly along the midgut (arrowheads). (D) Magnified view of boxed region
in (C), revealing intermingled populations of smaller vesicles containing only
nAPPL fragments (green arrowhead), cAPPL fragments (magenta arrowhead),
or both epitopes (white arrowhead). Scale bar = 5 µm in (A–C), 1.5 µm in (D).
migratory EP cells (Figures 7C,D). Although, Rab7 is typically
associated with late endosomes while Rab11 is associated
with recycling endosomes (Stenmark, 2009; Hutagalung and
Novick, 2011), recent studies have shown that Rab7 and
Rab11 converge during the formation of amphisomes, a large
intermediate organelle that gives rise to autophagosomes but
also participates in a variety of developmental and signaling
functions (Patel et al., 2013; Sanchez-Wandelmer and Reggiori,
2013; Szatmari et al., 2014; Bader et al., 2015). These
observations suggest that APPL may be alternatively trafficked
either into regions of active growth (where it can modulate
motile responses) or into an amphisome-like compartment
(for subsequent redistribution and/or processing), providing
a previously unrecognized mechanism for regulating the
developmental distribution of APP family proteins in embryonic
neurons.
FIGURE 5 | The cytoplasmic distribution of full-length APPL changes
with the motile behavior of developing neurons. Magnified views of EP
cells at progressive stages of embryogenesis, double- immunolabeled with
antibodies against nAPPL (green) and cAPPL (magenta) epitopes. (A) Trailing
EP cells that had not yet begun to migrate (55–58 HPF) or that had
transitioned from migration to axon outgrowth (65 HPF). (B) Leading EP cells
that were undergoing active locomotion (55–58 HPF) or that had transitioned
from migration to axon outgrowth (65 HPF). Arrowheads indicate examples of
the large vesicles labeled with both nAPPL and cAPPL antibodies (white
immunolabeling); this vesicle population was markedly more abundant in the
non-migratory neurons. (C) Quantification of the number of large vesicles
(>100 nm) that apparently contain full-length APPL. At 55 and 58 HPF, the
number of large vesicles was significantly reduced in leading EP cells,
compared to trailing EP cells (**p = 0.002 and ***p = 0.001, respectively; ns =
not significant). At 65 HPF, there was no significant difference in the number of
large perinuclear vesicles in trailing vs. leading EP cells (p = 0.106). Statistical
comparisons were performed using pairwise Student’s two-tailed t-tests; N ≥
10 per group; histograms show means ± SD. Scale bar in (A,B) = 5µm.
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FIGURE 6 | Different cleavage fragments of APPL are concentrated
within distinct domains of neurons in the developing Manduca CNS.
(A) Abdominal ganglion of an embryo (at 60 HPF) that was immunolabeled
with a combination of anti-APPL antibodies. As in the EP cells, large
cytoplasmic vesicles containing APPL holoprotein were abundant in most
neurons (white arrowheads). In addition, anti-nAPPL labeling (green) was more
abundant in the neuronal somata (located in the cortical regions of the
ganglia), whereas anti-cAPPL (magenta) was more abundant in both the
somata and their processes within the central neuropil regions, including
prominent fascicles of longitudinal axons. Anti-nAPPL antibodies also
immunolabeled peripheral macrophages (“m”) that do not themselves express
APPL but rather scavenge cleaved ectodomain fragments released by
neurons (unpublished observations). Similarly, an additional population of cells
within the ganglia immunolabeled only with anti-nAPPL but not anti-cAPPL
(yellow arrowheads). (B) Embryonic brain from the same developmental stage;
the large cytoplasmic vesicle population containing APPL holoprotein was
apparent in most neuronal somata (white arrowheads), interspersed with
smaller vesicles containing either nAPPL or cAPPL fragments. (C) Magnified
view of the brain shows neurons with vesicles containing the holoprotein (white
arrowheads), intermingled with smaller cells that were labeled only with
anti-nAPPL (yellow arrows). Scale bar = 30 µm in (A,B); 7 µm in (C).
Secretase Inhibitors Alter Both APPL
Trafficking and Neuronal Migratory
Behavior
In previous work, we demonstrated that APPL plays an
important role as a neuronal guidance receptor that interacts with
FIGURE 7 | APPL holoprotein is concentrated in an amphisome-like
compartment in GV1 cells and EP cells. (A,B) Examples of Manduca GV1
cells that were fixed and immunolabeled with a combination of antibodies
against different Rab proteins (shown in green) and APPL (only anti-cAPPL is
shown; magenta). Both anti-Rab7 (A) and anti-Rab11 (B) co-label a
population of large cytoplasmic vesicles containing APPL holoprotein
(arrowheads), similar to the vesicles found in developing neurons. (C,D)
Examples of migrating EP cells in fixed embryos (60HPF) that were
immunolabeled with the same combinations of antibodies. Both anti-Rab7 (C)
and anti-Rab11 (D) co-label the large cytoplasmic vesicles containing APPL
holoprotein (arrowheads). Scale bar = 7 µm.
heterotrimeric G protein Goα within the leading processes of the
EP cells (Swanson et al., 2005; Ramaker et al., 2013). We also
showed that APPL-Goα signaling normally prevents the neurons
from growing inappropriately into the interband regions of the
midgut: inhibiting APPL expression or Goα activation permitted
ectopicmigration and outgrowth, whereas hyperactivation of this
response caused a collapse/stall response that blocked normal
migration (Horgan and Copenhaver, 1998; Ramaker et al.,
2013, 2016). Based on these results, we hypothesized that the
accumulation of APPL within the leading processes of the EP
cells must be precisely regulated to prevent hyperactivation
of APPL-Goα signaling, whereby secretase-dependent cleavage
of transmembrane APPL would provide a mechanism for
terminating APPL-dependent responses (thereby preventing
inappropriate collapse-stall behaviors).
A prediction from this model is that preventing the normal
cleavage of membrane-associated APPL should increase the
relative abundance of APPL in the EP cell membranes and
enhance the normal activation of APPL-dependent retraction
responses. As already noted, treating Manduca embryos with
inhibitors targeting α-, β-, and γ-secretases caused predictable
changes in the cleavage of the holoprotein (Figure 1G).
Accordingly, we used our embryo culture assay to test whether
inhibiting different aspects of APPL processing in the EP cells
also affected their migratory behavior. For these experiments,
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FIGURE 8 | Blocking α-secretase activity increases membrane-associated APPL levels in the EP cells and inhibits their migration. (A) Examples of EP
cells in cultured embryos that were treated with different secretase inhibitors and then immunolabeled with a combination of anti-nAPPL (green) and anti-cAPPL
antibodies (magenta). (A1) EP cells in a cultured control preparation. (A2) EP cells treated with an α-secretase inhibitor showed increased levels of
membrane-associated full-length APPL (white). (A3) EP cells treated with a β-secretase inhibitor showed an increased number of cytoplasmic vesicles containing the
holoprotein (arrowheads). (A4) EP cells treated with a γ-secretase inhibitor showed an apparent increase in C-terminal fragments (magenta). (B) Quantification of the
relative amount of membrane-associated APPL (black histograms) in EP cells treated with different secretase inhibitors (normalized to adjacent interband regions in
each preparation). Treatment with α-secretase inhibitors caused a noticeable increase in membrane APPL that was significant in a pairwise comparison (*p < 0.02),
but not quite significant after applying the Bonferroni correction for multiple comparisons (p < 0.06). In contrast, none of the other secretase inhibitors affected the
relative levels of APP, nor was the intensity of Fas II immunoreactivity altered by any of these treatments (quantified in a separate channel; gray histograms). Statistical
comparisons between groups were performed using one-way ANOVA followed by unpaired Student’s two-tailed t-tests with the Bonferroni correction to obtain
reported p-values. N = 10 per group; histograms show means ± SD. (C) Examples of EP cell migration in cultured embryos (redrawn from camera lucida images of
immunolabeled preparations). (C1) Embryo that was fixed and immunolabeled at experimental onset (57 HPF); at this stage, the pre-migratory EP cells extended short
exploratory processes onto the midgut band pathways (“b”) but avoid the adjacent interband regions (“ib”). (C2) Control preparation that was allowed to develop in
culture for 18 h; the EP cells had migrated and extended axons posteriorly along the muscle band pathways (black arrowheads). (C3) Preparation that was treated
with an α-secretase inhibitor; EP cell migration and axon outgrowth were markedly reduced compared to controls, although there was no apparent increase in ectopic
migration or neuronal death. (D) Quantification of the extent of EP cell migration (black histograms) and outgrowth (gray histograms) along the midgut band pathways
in cultured embryos treated with different secretase inhibitors (distances normalized to controls in each experimental group). Treatment with α-secretase inhibitors
caused a significant reduction in both migration (***p < 0.001) and outgrowth (**p = 0.002), whereas treatment with β- and γ-secretase inhibitors had no apparent
effects on these aspects of EP cell development. Migration and outgrowth distances were normalized to mean values obtained from matched control preparations in
each experiment. Statistical comparisons between groups were performed using one-way ANOVA followed by unpaired Student’s two-tailed t-tests with the
Bonferroni correction to obtain reported p-values. N ≥ 16 per group; histograms show means ± SD. Scale bar in (A) = 5 µm; in (C) = 40 µm.
we treated cultured embryos just after the onset of EP cell
migration (at 57 HPF) with specific secretase inhibitors for
5 h, then fixed and immunolabeled the preparations with
anti-nAPPL, anti-cAPPL, and anti-Fas II (as an independent
membranemarker).We then quantified both the relative levels of
membrane-associated APPL and the extent of EP cell migration
and outgrowth.
Consistent with the images shown in Figures 3, 4, we found
that EP cells in cultured control preparations showed a moderate
level of full-length APPL at the membrane (Figure 8A1;
immunolabeled white), plus the same spectrum of cytoplasmic
vesicles containing the holoprotein (arrowhead), N-terminal
fragments (green), or C-terminal fragments (magenta). In
contrast, when we treated the EP cells with α-secretase inhibitors,
we detected an increase in full-length APPL immunoreactivity at
the plasma membrane (Figures 8A2, 8B), consistent with other
evidence that α-secretases predominantly cleave APP family
holoproteins at the cell surface (Sisodia, 1992; Zhang et al., 2012).
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In contrast, inhibiting β-secretase activity caused no
significant change in membrane associated APPL (Figure 8B)
but did markedly increase the number of large cytoplasmic
vesicles containing the holoprotein (Figure 8A3, arrowheads).
Given our evidence that this vesicle class represents Rab7/Rab11-
positive amphisomes (Figure 7), these data suggest that a
substantial portion of full-length APPL normally traffics into this
compartment in a developmentally regulated manner, where it is
cleaved by β-secretase. Interestingly, treatment with γ-secretase
inhibitors also did not significantly alter the levels of full-length
APPL at the plasma membrane (Figure 8B) but did produce
a noticeable increase in C-terminal fragments (Figure 8A4,
magenta). This result indicates that low basal γ-secretase
activity normally removes CTFs from the neuronal membranes
following α-secretase cleavage, consistent with current models
that γ-secretase processing of APP occurs only after initial
cleavage by α- or β-secretases (Turner et al., 2003; Zhang et al.,
2012). By comparison, Fas II levels were not significantly affected
by any of the secretase treatments (Figure 8B, gray histograms).
When we subsequently analyzed the motile behavior of the
EP cells in these preparations, we found that treatment with α-
secretase inhibitors resulted in a significant inhibition of both
migration and outgrowth (Figure 8C), although we observed no
obvious changes in neuronal viability. Quantification of these
results are shown in Figure 8D (∗∗p = 0.002; ∗∗∗p < 0.001;
determined using unpaired Student’s two-tailed t-tests with the
Bonferroni correction). In contrast, inhibitors targeting β- and
γ-secretases had no detectable effect on migration and outgrowth
(Figure 8D), indicating that altered CTF and AICD levels did
not perturb EP cell development over this 5-h culture period.
These results support the model that increased APPL levels in the
leading processes of the EP cells permits exaggerated activation of
APPL-Goα signaling, which in turn restricts normal migration.
Trafficking and Processing of
Fluorescently Tagged APPL and APP in
Cultured Drosophila Neurons
To complement our immunohistochemical analysis of APPL in
Manduca, we also expressed constructs encoding a fluorescently
double-tagged version of Drosophila APPL in the fly CNS,
using the GAL4/UAS system (Brand and Perrimon, 1993).
For this experiment, the sequence encoding enhanced Green
Fluorescence Protein (eGFP) was inserted immediately after
the signal sequence of APPL, while the sequence encoding
monomeric Red Fluorescence Protein (mRFP) was inserted in-
frame with the C-terminus of the coding domain (Figure 9A).
After inducing its expression in the developing eye (using GMR-
GAL4), we could readily detect the full-length double-tagged
protein (APPL-tag) in western blots of head lysates labeled
with anti-DsRed (Figure 9B, lane 1; black arrow); the slightly
smaller band (open arrow) may represent a partially glycosylated
immature form (Weidemann et al., 1989; Swanson et al., 2005).
We could also detect a candidate CTF band at ∼42 kDa,
consistent with the predicted size of endogenous CTFs (∼12–
15 kDa) plus C-terminal mRFP, although we could not resolve
α-CTFs from β-CTFs in this assay. Likewise, in western blots
FIGURE 9 | Expression and processing of fluorescently double-tagged
APPL and APP695 in Drosophila. (A) Schematic diagram of constructs
encoding full-length Drosophila APPL and human APP695, in frame with
N-terminal enhanced Green Fluorescent Protein (GFP; inserted downstream of
their signal sequence) and C-terminal monomeric Red Fluorescent Protein
(mRFP). E1 and E2 indicate extracellular protein interaction domains; “ss”
indicates signal sequences; TM indicates transmembrane domains (compare
with Figure 1). Cleavage sites for α, β-, and γ-secretases are indicated by
arrows; note that the relative positions of the α and β cleavage sites in APPL
are reversed, compared to APP695. (B) Western blot of head lysates from flies
expressing double-tagged APPL (APPL-tag) and APP695 (APP-tag) under the
control of the eye-specific promoter construct GMR-GAL4. Immunoblot was
labeled with anti-DsRed (targeting mRFP). The full length, mature forms (black
arrows) and partially glycosylated immature forms (open arrows) of both
constructs were expressed at similar levels. Smaller bands at ∼42 kDa
represent CTF fragments generated by α- and β-secretase cleavage (not
distinguished in this gel). (C) Western blot of head lysates from the same fly
lines immunolabeled with anti-GFP; full-length mature forms (black arrows) and
cleaved ectodomain fragments (black arrowheads) of both constructs could
be readily detected. The smaller size of cleaved ectodomains from
double-tagged APP695 reflects the presence of larger intervening sequences
between the E1 and E2 domains in Drosophila APPL (illustrated in A). Lower
gel shows anti-actin staining (“Act”) as a loading control. (D) Western blot of
head lysates from flies expressing either double-tagged APP695 (APP-tag) or
untagged full-length APP695 (APP), labeled with an antibody specific for the
N-terminus of human APP. Upper bands (black arrows) indicate full-length,
mature holoprotein; lower bands (arrowhead) represent cleaved ectodomain
fragments. The larger size of the bands in the APP-tag lane is consistent with
the combined molecular weight of APP695 plus mRFP and eGFP. Lower gel
shows anti-tubulin staining (“Tub”) as a loading control.
labeled with anti-GFP (Figure 9C, lane 1), we could detect
both full-length (arrow) and cleaved ectodomain fragments
(arrowhead) of double-tagged APPL (APPL-tag), recapitulating
our analysis of endogenously expressed APPL in Manduca
(Figures 1B,C). In the lower gel, “Act” indicates actin as a loading
control.
Using similar methods, we also expressed a double-tagged
construct of human APP695 in Drosophila neurons (Figure 9A;
APP-tag). As with our APPL construct, we could detect both
full length and immature forms of double-tagged APP695 in
western blots of head lysates labeled with anti-mRFP (Figure 9B,
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lane 2), as well as candidate CTF fragments at ∼42 kDa
(arrowhead). Likewise, we could detect both the full-length
construct and cleaved ectodomain fragments in immunoblots
labeled with anti-GFP (Figure 9C, lane 2). The smaller size of
the GFP-tagged ectodomain fragments derived from APP695
(black arrowhead) reflects the fact that fly APPL contains
larger intervening sequences between its E1 and E2 extracellular
domains (Figure 1A). “Act” in lower gel indicates actin as a
loading control. As an additional control, we compared the
expression of our double-tagged APP695 construct with an
untagged version of APP695 in western blots labeled with an
antibody specific for N-terminal APP. As shown in Figure 9D,
we could detect the full-length forms (arrows) and cleaved
ectodomain fragments (arrowheads) of both constructs at their
predicted sizes. “Tub” in lower gel indicates tubulin as a loading
control. These results demonstrate that our double-tagged
constructs of both APPL and APP695 undergo similar patterns
of secretase cleavage as seen with endogenously expressed APPL
(Figure 1).
Accordingly, we expressed these constructs in the CNS and
prepared primary cultures of brain neurons (Figure 10). In
some preparations, we subsequently fixed and immunolabeled
the neurons with anti-GFP and anti-DsRed to enhance the
detection of N-terminal cleavage fragments (carrying only the
eGFP tag; green) vs. C-terminal fragments (carrying only the
mRFP tag; magenta) and the holoprotein containing both
tags (visualized as white in merged images). As in Figure 2,
nAPPL (GFP) and cAPPL (mRFP) in Figure 10 are presented
as gray scale images for the individual channels but shown
in green and magenta (respectively) in the merged images,
whereby co-localization appears white (right hand column).
Notably, we observed that double-tagged APP695 and APPL
were distributed in a pattern that coincided with stages of
outgrowth and retraction (Figure 10), closely matching the
patterns that we observed for endogenous APPL in cultured
Manduca neurons (Figure 2). We could readily visualize the
full-length proteins within the leading processes of neurons
undergoing active outgrowth (at 1 DIV; Figure 10A, arrows).
At higher magnification (Figure 10B), we could also distinguish
distinct populations of vesicles that contained either N-
terminal fragments (presumably sAPP/sAPPL ectodomains;
green arrowheads), C-terminal fragments (including CTFs
and AICDs; magenta arrowheads), as well as larger vesicles
containing the holoprotein (white arrowheads). Within their
growth cone regions (Figure 10C), vesicles containing only N-
terminal fragments (green arrowheads) were more concentrated
near their leading edges, often in the vicinity of membrane-
associated holoprotein (white arrowheads), whereas vesicles
containing only C-terminal fragments (magenta arrowheads)
were more concentrated within more central domains of the
growth cones and proximal neurites. By comparison, in neurons
that had ceased to extend processes or were undergoing
retraction, little or no full-length protein was detectable in their
distal processes (Figure 10D), leaving a diffuse distribution of
C-terminal fragments (magenta arrowheads) throughout their
neurites while the holoprotein accumulated in their cell bodies,
similar to the pattern of APPL fragments seen in retracting
FIGURE 10 | Trafficking and processing of double-tagged APPL in
cultured Drosophila neurons corresponds to their stage of outgrowth.
Neurons harvested from the CNS of Drosophila white pupae expressing
fluorescently double-tagged APPL were grown on coverslips for 1–8 days
before fixation and imaging. GFP (nAPPL) and mRFP (cAPPL) are shown
individually as gray scale images but are shown in green and magenta
(respectively) in the merged images, whereby co-immunolabeling appears
white (right hand column). (A) In neurons that had recently commenced
outgrowth (1 DIV), full-length APPL could be detected in the leading tips of
their growth cones (arrows), similar to the distribution of endogenous APPL in
cultured Manduca neurons (see Figure 2A). In addition, N-terminal fragments
(green) were relatively more abundant in their cell bodies, while C-terminal
fragments (magenta) were detected throughout the neurons and their
processes. (B) Higher magnification view of the cell body of a cultured neuron
at 2 DIV. Distinct vesicle populations could be detected that contained either
nAPPL fragments (green arrowheads) or cAPPL fragments (magenta
arrowheads), while an additional population of larger vesicles apparently
contained the holoprotein (white arrowheads). (C) Higher magnification view of
the growth cone of a neuron at 2 DIV. Vesicles containing only nAPPL
fragments (green arrowheads) were more concentrated in the peripheral
domain, in the vicinity of the holoprotein at the leading margins of the growth
cone white arrowheads), while vesicles containing cAPPL fragments (magenta
arrowheads) were relatively more abundant within the central domain. (D)
Older neuron that was undergoing retraction (at 6 DIV); full-length APPL was
no longer detectable within its distal processes (open arrows), and N-terminal
fragments were largely confined to the cell body (green arrowheads), leaving a
diffuse distribution of C-terminal fragments throughout the neurites (magenta
arrowheads). These results suggest that the holoprotein is preferentially
transported to the distal processes of developing neurons during periods of
active outgrowth. Scale bar = 5 µm in (A,D); 1.5 µm in (B), 1 µm in (C).
Manduca neurons (Figure 2E). In some neuronal somata, we
also could detect C-terminal fragments within their nuclei
(Supplementary Figure S2, arrowhead), consistent with recent
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evidence that AICD fragments can regulate transcriptional
responses in mammalian cells (Cao and Südhof, 2001; Pardossi-
Piquard and Checler, 2012) and potentially in the fly brain
(Khanna and Fortini, 2015). These results demonstrate that the
developmental regulation of our double-tagged constructs closely
matches the pattern seen for endogenously expressed APPL.
Fluorescently Tagged APP Family Proteins
Exhibit Complex Patterns of Dynamic
Trafficking in Cultured Drosophila Neurons
To investigate the dynamic nature of the vesicle populations
containing different APP/APPL fragments, we also performed
time-lapse imaging of primary neurons expressing our constructs
under the control of elav-GAL4. By 1 day in culture (Figure 11A),
many of the neurons had extended elaborate processes
with a diversity of fluorescently labeled vesicle populations,
some of which contained the holoprotein and others that
contained either N- or C-terminal fragments. Even after 4
DIV (Figure 11B), neurons with motile processes continued
to exhibit a similar complex pattern of APPL trafficking
and processing. In most neurons, all three vesicle subtypes
underwent bi-directional transport in both proximal and
distal domains of the neurons (Supplementary Movies S1, S2).
As illustrated in Figure 11C (boxed region in Figure 11A),
we observed a substantial number of vesicles containing the
holoprotein moving in either anterograde (white arrowhead)
or retrograde directions (white arrow); Figure 11C also shows
an example of vesicles containing only C-terminal fragments
(magenta) undergoing rapid retrograde movement (magenta
arrowhead). Figure 11D (boxed region in Figure 11B) shows
an example of a vesicle containing only N-terminal fragments
(green) that initially was transported anterogradely into
the growth cone of a neurite (Figure 11D, panels 1–5), but
then underwent a rapid transition and was transported back
toward the cell body (panels 6–10). Quantification of these
events showed that the anterograde and retrograde transport
of the different vesicle classes occurred with approximately
equal frequencies (Figure 11E); apparent transport rates
varied from 0.8–1.2 µm/s. However, not all cultured CNS
neurons showed the same patterns of APPL trafficking
and localization. For example, as shown in Supplementary
Movie S3, some neurons expressed double-tagged APPL
predominantly as a holoprotein that was dynamically distributed
throughout their processes, with comparatively little differential
trafficking of N- and C-terminal fragments. As described
below, we have discovered that different neuronal subtypes
also exhibit dramatically different patterns of APP/APPL
cleavage within the CNS, revealing a previously unrecognized
degree of cell type-specific regulation that affects this complex
process.
APP Family Proteins Undergo Cell-Specific
Patterns of Trafficking and Processing
In vivo
Based on these in vitro results, we also examined the patterns
of double-tagged APPL and APP695 expression at different
developmental stages within the Drosophila nervous system.
FIGURE 11 | Dynamic trafficking of fluorescently double-tagged APPL
and its fragments in cultured Drosophila neurons. (A,B) Small clusters of
partially dispersed Drosophila neurons expressing fluorescently double-tagged
APPL (via elav-GAL4) at 1 and 4 DIV, respectively. Numerous vesicles
containing either N-terminal fragments (green), C-terminal fragments
(magenta), or the holoprotein (white immunolabeling) could be seen
throughout the neurons and their processes. (C) Single frames from a
time-lapse of the boxed region in A (See also Supplementary Movie S1). White
arrow indicates a vesicle containing the holoprotein undergoing retrograde
trafficking toward the soma; white arrowhead indicates another vesicle
containing the holoprotein in the same neurite undergoing anterograde
transport away from the soma. Magenta arrowhead indicates vesicle in a
different neurite containing only C-terminal fragments undergoing retrograde
transport. (D) Single frames from a time-lapse movie of the boxed region in B
(See also Supplementary Movie S2). Green arrowhead indicates a vesicle
containing only N-terminal fragments that was initially transported anterograde
to the tip of a growing process (panels 1–5) and then reversed direction
(panels 6–10) to undergo retrograde transport back toward the soma (M–Q).
Scale bar = 6 µm in (A,B), 2 µm in (C,D). (E) Quantification of the number of
vesicles containing either APPL holoprotein (white histograms), N-terminal
fragments (green histograms), or C-terminal
(Continued)
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FIGURE 11 | Continued
fragments (magenta histograms) that underwent anterograde vs. retrograde
transport in time-lapse movies of neurons shown in (A,B). Frames from movies
selected at 1 frame/s (approximate transport rates varied from 0.8 to 1.2
µm/s). In (E), each histogram represents average values calculated for 15–20
cells per group, 4 events per cell.
When we expressed these constructs pan-neuronally (with
Appl-GAL4 or elav-GAL4), we could readily visualize the
fluorescently tagged proteins in living animals (Figure 12). As
with our primary neuronal cultures expressing the double-tagged
constructs (Figure 10), nAPPL (GFP), and cAPPL (mRFP) are
presented as gray scale images for the individual channels
but shown in green and magenta (respectively) in the merged
images, whereby co-localization appears white. By focusing
through the abdominal cuticle (Figure 12B; magnified box 1 in
Figure 12A), we could distinguish transport vesicles containing
either N-terminal fragments (green arrowheads) or C-terminal
fragments (magenta arrowheads) vs. the holoproteins (white
arrowheads) within the motor axons extending to posterior
muscles. Within neuromuscular junction regions (NMJ) on
the target muscles (Figure 12C; magnified box 2), N-terminal
fragments tended to concentrate within the more distal regions
of the NMJ, including synaptic boutons (green arrowhead),
while C-terminal fragments were more abundant in proximal
regions (magenta arrowhead). In contrast, full-length APPL and
APP appeared more sparsely distributed throughout the NMJ,
only occasionally being detectable within boutons (Figure 12C,
white arrowheads). These results support previous evidence that
APP family proteins are rapidly processed and removed from
synaptic membranes soon after their insertion (Ashley et al.,
2005).
Unexpectedly, we observed considerable heterogeneity in
the pattern of APP/APPL processing within different CNS
neurons when we expressed our constructs pan-neuronally
(with elav-GAL4 or Appl-GAL4). Within the fused ventral
ganglia of third instar larvae, we found that different neuronal
subsets showed markedly different concentrations of N-
vs. C-terminal fragments (Figure 12D, green and magenta
arrowheads). This heterogeneity was even more dramatic in
the adult brain (Figures 13A,B), where some neurons were
clearly enriched in the holoprotein (white arrows), while other
neurons predominantly contained N-terminal (green arrows)
or C-terminal fragments (magenta arrows), and these different
neuronal populations were intermingled throughout the brain.
Of note is that we detected a similar spectrum of expression
patterns with both our APP695 or APPL constructs, providing
further evidence that these proteins are functionally as well as
structurally conserved.
To explore whether these cell-specific patterns of APP/APPL
processing corresponded to particular neuronal classes, we
also expressed our constructs specifically in dopaminergic
neurons (with Ddc-GAL4), octopaminergic neurons (with
Tdc1-GAL4), or cholinergic neurons (with ChaAT-GAL4).
Once again, we discovered a surprising amount of heterogeneity
in the patterns of trafficking and processing within each
FIGURE 12 | Double-tagged APP695 is trafficked and processed in
complex patterns within the larval CNS of Drosophila. Images were
collected through the cuticle of living 3rd instar Drosophila larvae expressing
fluorescently double-tagged APP695. (A) Low-magnification view of abdominal
nerves containing motor neurons expressing double-tagged APP695
pan-neuronally (via Appl-GAL4). (B) Magnified view of boxed region #1 in A.
Intermingled transport vesicles containing only N-terminal fragments (green
arrowheads), C-terminal fragments (magenta arrowheads), or holoprotein
(white arrowheads) could be detected in the fasciculated axons of an
abdominal nerve. (C) Magnified view of boxed region #2 in A, focused on a
neuromuscular junction (NMJ). N-terminal fragments tended to concentrate in
the most distal domains of the NMJ (green arrowhead), while C-terminal
fragments were more abundant in more proximal domains (magenta
arrowhead). Full-length APP (white) was also detectable in certain regions of
the NMJ (white arrowheads), reminiscent of the distribution of the holoprotein
in some growth cone filopodia but not others (Figure 10). (D) Images of
neurons within the fused segmental ganglia of the CNS. Different subsets of
neurons exhibited markedly different concentrations of N-terminal
(green arrowhead) or C-terminal fragments (magenta arrowhead) as well as the
holoprotein (white arrowhead). Scale bar = 40 µm in (A); 5 µm in
(B,C); 25µm in (D).
neuronal subtype. For example, different sets of dopaminergic
neurons preferentially accumulated either N-terminal APP695
or C-terminal fragments in their cell bodies (Figure 13C).
At higher magnification, we observed that some of these
neurons concentrated N-terminal fragments in their cell
bodies and proximal neurites (Figure 13D, green arrowheads),
with C-terminal fragments being localized to more sparse
vesicle populations (magenta arrowheads). However, other
dopaminergic neurons contained abundant C-terminal
fragments that were distributed throughout their somata
and neurites (Figure 13E, magenta), with more variable
vesicle populations containing N-terminal fragments (green
arrowheads) or the holoprotein (white arrowheads). Likewise,
when we drove expression in octopaminergic neurons
(Figure 13F), we detected highly variable distributions of
N- vs. C-terminal fragments in neighboring somata. In contrast,
when we drove expression in cholinergic neurons (Figure 13G),
we found that N-terminal fragments were generally concentrated
in their cell bodies, with C-terminal fragments being localized
to a discrete population of larger cytoplasmic vesicles (magenta
arrowheads).
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FIGURE 13 | Different CNS neurons process double-tagged APP695 in
diverse patterns within the CNS of Drosophila. Panels show neurons
within the brains of Drosophila adults expressing double-tagged APP695
under the control of different GAL4 driver lines. (A) Neurons in the brain of an
adult fly expressing double-tagged APP695 pan-neuronally (via Appl-GAL4).
Intermingled populations of neurons showed enhanced concentrations of
either N-terminal fragments (green), C-terminal fragments (magenta), or the
holoprotein (white) in their somata. (B) Higher magnification view of the brain in
A (arrowheads indicate the same neurons at both magnifications). (C–G)
Expression of double-tagged APP695 in dopaminergic neurons (via
Ddc-GAL4). (C) Low magnification view of the adult brain revealed that
different subsets of dopaminergic neurons process APP695 in dramatically
different patterns, whereby many neurons predominantly accumulated
N-terminal fragments in their somata (green); a smaller number predominantly
accumulated C-terminal fragments (magenta). White arrowhead indicates
larger vesicles containing the holoprotein. (D) Example of two dopaminergic
neurons that showed robust accumulation of N-terminal fragments within
numerous small vesicles in their somata (green arrowheads), as well as larger
vesicles containing the holoprotein (white arrowheads). In contrast, C-terminal
(Continued)
FIGURE 13 | Continued
fragments were concentrated in more sparse vesicle populations in their
primary neurites (magenta arrowheads). (E) Another pair of dopaminergic
neurons that exhibited abundant small vesicles containing C-terminal
fragments throughout their somata and primary neurites (magenta),
interspersed with more variable vesicle populations containing N-terminal
fragments or the holoprotein. (F) Two octopaminergic neurons expressing
double-tagged APP695 (via Tdc-GAL4), exhibiting concentrated N-terminal
fragments in their somata (green) and quite variable populations of vesicles
with C-terminal fragments (magenta arrowhead). (G) A cluster of cholinergic
neurons expressing double-tagged APP695 (via ChAT-GAL4), exhibiting
numerous small vesicles containing N-terminal fragments (green) and sparse
populations of larger vesicles containing C-terminal fragments (magenta).
Scale bar = 25 µm in (A,C); 15 µm in (B); 2 µm in (D–G).
Fluorescently Tagged APP Family Proteins
Exhibit Complex Patterns of Trafficking
In vivo
To complement our in vitro analysis of APP/APPL dynamics
in vitro, we also used live cell imaging protocols to visualize
double-tagged APPL and APP695 in neurons within the CNS.
Once again, we found that both holoproteins and their
cleavage products were assorted into different vesicle classes
that underwent both anterograde and retrograde transport.
For example, in cholinergic neurons expressing double-tagged
APPL (via ChAT-GAL4; Figure 14), we found that N-terminal
fragments (green) localized to numerous small vesicles that were
abundant throughout the neurons, while C-terminal fragments
(magenta) accumulated in larger vesicles that were distributed
more sparsely throughout their neurites (Figures 14A–C). We
also noted that vesicles containing either N-terminal or C-
terminal fragments appeared to be associated with different sets
of microtubules (Figure 14C; boxed region 1): N-terminal APPL
fragments (in smaller vesicles) were confined to the core region
of neurites, while vesicles containing C-terminal fragments were
associated with tracks throughout their entire width. When
visualized by time-lapse imaging (Supplementary Movie S4), the
smaller vesicles containing N-terminal fragments were difficult
to resolve but could be seen moving bi-directionally throughout
the processes. Concurrently, larger vesicles containing only
C-terminal fragments exhibited cycles of anterograde and
retrograde transport throughout the neurites, as shown in
time-lapse images from boxed regions 2 and 3, respectively
(Figures 14D,E).
Lastly, to investigate how APP family protein trafficking is
regulated in the context of neuronal development in vivo, we
expressed our constructs specifically in the eye (via GMR-GAL4),
and then performed time-lapse imaging of APP/APPL trafficking
within developing adult photoreceptors (using cultured larval
eye disc-brain preparations). The region of the developing
eye disc that we imaged for these experiments is shown
schematically in Figure 15A (red box). By taking advantage
of the morphogenetic wave of neuronal differentiation that
occurs during adult fly eye formation (Ready et al., 1976;
Tomlinson and Ready, 1987), we could compare the dynamics
of our fluorescently tagged proteins in younger vs. older
photoreceptors (Figures 15A,B), coinciding with phases of their
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FIGURE 14 | In vivo trafficking of fluorescently double-tagged APPL
within Drosophila CNS neurons. Two cholinergic neurons expressing
double-tagged APPL (via ChAT-GAL4) in the adult fly brain. (A) Low
magnification view revealed concentrations of the holoprotein (white) in their
somata and populations of vesicle containing N-terminal (green) or C-terminal
vesicles (magenta) throughout their primary neurites. (B) Higher magnification
view of the two neurons shown in (A); N-terminal fragments in numerous small
vesicles (green) were distributed throughout the somata and primary neurites,
while larger vesicles contained C-terminal fragments (magenta) or the
holoprotein (white). (C) Higher magnification view of boxed region 1 depicted
in (A) (shown in all three channels). Numerous small vesicles containing
N-terminal fragments of APPL were preferentially localized to microtubule
tracks within core domain of the primary neurite, while larger vesicles
containing C-terminal fragments (arrowheads) were associated with
microtubule tracks throughout the circumference of the neurite. (D) Single
frames from a time-lapse movie taken from box 2 in (A) (cAPPL channel only,
shown in gray scale); see also Supplementary Movie S4. Arrow and arrowhead
indicate two vesicles containing C-terminal fragments undergoing anterograde
trafficking (away from the soma). (E) Single frames from a time-lapse movie
taken from box 3 in (A) (cAPPL channel only, shown in gray scale). Arrowhead
indicates one of several vesicles containing C-terminal fragments
undergoing retrograde trafficking (toward the soma). Scale bar = 8 µm in (A);
2 µm in (B–E). Frames from movies selected every 2 s (approximate transport
rates are 1.2µm/s).
initial outgrowth and subsequent synaptogenesis. Intriguingly,
we found a marked difference in the relative abundance of
the holoprotein vs. its cleavage products in photoreceptors
of different ages, once again indicating that APP trafficking
and processing is developmentally regulated (similar to our
analysis of embryonic neurons). In younger photoreceptors
undergoing axon outgrowth (Figure 15B, “y”), we observed
a diffuse distribution of the holoprotein (white), while older
neurons (“o”) contained more C-terminal fragments (magenta),
similar to the accumulation of C-terminal fragments in cultured
neurons after they stopped extending processes (Figures 2D,
10D). At intermediate magnification (Figure 15C; boxed region
in Figure 15B), we detected a diffuse distribution of N-terminal
fragments throughout the photoreceptors (green), while C-
terminal fragments were generally confined to larger vesicles
(magenta), similar to the distribution of N- and C-terminal
fragments seen in other neurons expressing these constructs
(Figures 11–14). We also noted the presence of a larger
vesicle population containing the holoprotein (Figure 15C, white
arrowheads), resembling the amphisome-like vesicles identified
in Manduca (Figures 5–7). Likewise in regions containing
photoreceptor axons growing toward the optic stalk (Figure 15D;
boxed region in Figure 15C), we could distinguish different
vesicle populations containing either the holoprotein (white
immunolabeling), C-terminal fragments (magenta arrowheads),
or N-terminal fragments (green arrowheads), recapitulating the
differential distribution of APPL cleavage products seen in other
developing neurons both in vitro and in vivo.
When we performed time-lapse imaging of the developing
photoreceptors in cultured larval eye disc-brain complexes
(Supplementary Movie S5), we also observed distinct vesicles
classes containing either N- or C-terminal fragments (or
the holoprotein) undergoing complex, dynamic patterns of
trafficking. As with the cholinergic neurons shown in Figure 14,
we could visualize vesicles containing different fragments moving
in both apical (Figure 15E) and basal directions (Figure 15F),
although once again, the comparatively small size of vesicle
containing N-terminal fragments made them more difficult
to resolve. Surprisingly, only ∼15% of the vesicles were
positive for both GFP and mRFP, indicating that they contain
the full-length protein. In addition, we observed twice as
many vesicles containing N-terminal fragments compared to
vesicles containing C-terminal fragments, which (as noted
above) were transported both anterogradely and retrogradely
in all developmental stages examined. These in vivo results
complement our experiments in cultured neurons, providing a
novel perspective on the dynamics of APP family proteins in both
developing and mature neurons.
DISCUSSION
Together, our results in both Manduca and Drosophila provide
new evidence that APP family proteins are subject to a complex
pattern of trafficking and processing within the nervous system,
whereby the intracellular distributions of the holoproteins and
their cleavage fragments can be modulated to meet the particular
requirements of different neuronal subtypes. As with other
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FIGURE 15 | In vivo trafficking of fluorescently double-tagged APPL within Drosophila photoreceptors is developmentally regulated. (A) Schematic
diagram of the developing eye disc in Drosophila; mf = morphogenetic furrow of the eye disc (boundary of photoreceptor differentiation); pr = newly differentiated
photoreceptors that are in the process of extending axons through the optic stalk into the optic lobe of the brain; “o” indicates older photoreceptors; “y” indicates
younger photoreceptors. Red box indicates the equivalent region of the immunostained preparation shown (B). (B) Low magnification view of developing
photoreceptors in a cultured eye disc from a larva expressing double-tagged APP695 (via GMR-GAL4). Younger photoreceptors (“y”; near the morphogenetic furrow)
(Continued)
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FIGURE 15 | Continued
that had recently begun to extend axons were enriched with vesicles containing the holoprotein (white) and nAPP fragments (green), whereas older photoreceptors
(“o”) exhibited many more large vesicles containing cAPP fragments (magenta). (C) Higher magnification view of boxed region in (B). N-terminal APP fragments were
present in numerous small vesicles throughout the photoreceptors and their axons, while cAPP fragments were concentrated in more dispersed larger vesicles.
Photoreceptor somata also exhibited larger cytoplasmic vesicles containing the holoprotein (white arrowheads), similar to other neurons in both Manduca and
Drosophila. (D) Higher magnification view of boxed region in (C). Photoreceptor axons contained intermixed populations of vesicles with either nAPP fragments (green
arrowhead), cAPP fragments (magenta arrowheads), or the holoprotein (white immunolabeling). (E,F) Single frames from a time-lapse of the preparation shown in (B)
(magenta channel only; see Supplementary Movie S5). Vesicles containing cAPP fragments could be seen moving in both apical (E) and basal directions (F) within the
elongated photoreceptor cell bodies. Scale bar = 5 µm in (B); 3 µm in (C); 0.75 µm in (D); 8 µm in (E,F). Frames from movies selected every 2 s (approximate
transport rates are 2 µm/s).
APP family proteins, insect APPL is subject to cleavage by a
combination of α, β, and γ-secretases (Figures 1G–J), consistent
with the identification of all three secretase classes in multiple
insect systems (Luo et al., 1990; Ramabhadran et al., 1993;
Fossgreen et al., 1998; Greeve et al., 2004; Groth et al., 2010;
Bolkan et al., 2012; Prussing et al., 2013; Pace et al., 2014; Bourdet
et al., 2015; Lavore et al., 2015; Zheng et al., 2015). Likewise, our
studies showed that Manduca APPL is preferentially cleaved by
α-secretases under normal circumstances, as previously reported
for both Drosophila APPL and human APP695 (Haass et al., 2012;
Wentzell et al., 2012; Zhang et al., 2012). We also found that
treatment with a combination of α- and γ-secretase inhibitors in
our Manduca assays resulted in a detectable increase in β-CTF
levels (Figure 1H), indicating that blocking α-secretase activity
promoted alternative processing by BACE. Similar results have
been reported in mammalian systems, whereby diverting APP695
from the α-secretase pathway results in enhanced BACE cleavage
and elevated Aβ production (Kins et al., 2006; Zhang et al., 2011;
Haass et al., 2012). Although the exact residues in APPL that are
targeted by secretases have still not been identified, our results
support previous evidence that the relative positions of the α-
and β-cleavage sites in insect APPL are reversed, relative to their
positions in APP695 (Carmine-Simmen et al., 2009; Groth et al.,
2010). As a result, β-CTFs derived from endogenously expressed
APPL are smaller than α-CTFs (Figures 1G,I,J). Nevertheless,
recent studies have shown that an Aβ-like fragment derived from
DrosophilaAPPL (dAβ) can induce neurodegenerative responses,
similar to Aβ fragments derived from APP (Carmine-Simmen
et al., 2009; Wentzell and Kretzschmar, 2010). Whether Aβ-
like fragments derived from APPL also regulate physiological
aspects of neuronal function (as suggested for mammalian Aβ)
remains to be explored. Lastly, our detection of C-terminal
APPL fragments within neuronal nuclei in both immunolabeled
preparations and in neurons expressing the fluorescently tagged
constructs (Supplementary Figure S2) supports other evidence
that AICD fragments can regulate gene transcriptional responses
under both normal and pathological circumstances (Kimberly
et al., 2001; Cao and Sudhof, 2004).
By comparing the distributions of endogenous APPL in
both Manduca and Drosophila with epitope-tagged constructs
of APPL and APP695 (expressed in Drosophila neurons), we
found that a considerable portion of newly generated APP/APPL
is rapidly processed within neuronal cell bodies before being
packaged into distinct classes of transport vesicles, so that both
N- and C-terminal cleavage products (as well as the holoprotein)
can be preferentially targeted to distal sites of release. Similar
observations have been reported for APP family proteins in
mammalian cells (Back et al., 2007; Muresan et al., 2009; Villegas
et al., 2014; Niederst et al., 2015). The fact that we routinely
observed all of these vesicle populations undergoing anterograde
and retrograde transport (both in vitro and in vivo) argues that
the dynamic distribution of these proteins can be regulated by
a combination of intrinsic and extrinsic factors encountered by
neurons, depending on their developmental context. Whether
newly synthesized APPL must first undergo transcytosis from
the plasma membrane (as suggested for APP) or can be directly
packaged into secretory vesicles for transport remains to be
explored (Kamal et al., 2001; Andersen et al., 2005; Haass et al.,
2012;Muresan and LadescuMuresan, 2015; Niederst et al., 2015).
However, our results support the proposal that APP processing
can be regulated at multiple sites to match the physiological
needs and pathological stresses experienced by neurons within
the brain (Kamal et al., 2001; Nikolaev et al., 2009; Szodorai et al.,
2009; Niederst et al., 2015).
In both our in vitro and in vivo assays, we found that APPL
trafficking closely matched the motile behaviors of developing
neurons, whereby the holoprotein became concentrated in
their leading processes and growth cones of their elongating
axons (Figures 2, 4, 10). Once inserted into the plasma
membrane, however, the holoprotein is rapidly cleared by
secretase processing, providing a mechanism for preventing its
over-accumulation while terminating APPL-dependent signaling
responses. These results are consistent with previous studies
showing that APP family proteins are upregulated during periods
of active migration and outgrowth in mammalian cells (De
Strooper and Annaert, 2000; Sabo et al., 2003; Rice et al.,
2012; Sosa et al., 2013), but then undergo rapid turnover
once inserted into the plasma membrane (Lyckman et al.,
1998; Perez et al., 1999; Tam and Pasternak, 2015; van der
Kant and Goldstein, 2015). Similarly, work in Drosophila has
shown that APPL expression is dynamically regulated during
metamorphosis and following acute brain injury, whereby
APPL levels are reduced in axons undergoing retraction and
dramatically upregulated during periods of rapid regrowth and
synaptogenesis (Torroja et al., 1996; Leyssen et al., 2005). How
these patterns are modulated in a cell type-specific manner
remains to be determined. Nevertheless, our results provide
new evidence that the dynamic regulation of APP family
proteins in developing neurons is precisely coordinated with
their motile behaviors, providing an important mechanism
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for modulating their responses to cues that affect neuronal
differentiation.
In addition, our studies revealed a previously unrecognized
aspect of APP/APPL trafficking that is also developmentally
regulated. Prior to the onset of EP cell migration (in cultured
embryos) or neurite outgrowth (in primary neurons), we
found that a substantial proportion of the holoprotein was
initially targeted to an intracellular compartment resembling
Rab7/Rab11-positive amphisomes (Figures 2, 5, 7), which have
been implicated in a variety of signaling pathways as well
as autophagosome generation (Patel et al., 2013; Sanchez-
Wandelmer and Reggiori, 2013; Bader et al., 2015). Once
the neurons commenced active motility, however, APPL
concentrations in this amphisome compartment diminished
dramatically, concurrent with the increased trafficking of the
holoprotein to their leading processes and growth cones (as noted
above). Only when neurons had completed their differentiation
and established mature synaptic connections did we again
observe an increase in amphisomes containing APPL. Most
neurons within the developing Manduca CNS also contained
these amphisome-like vesicles enriched in APPL (Figure 6), as
noted in previous studies on Drosophila (Torroja et al., 1996).
These observations suggest that the transient sequestration of
APP family proteins into this compartment might provide
a novel developmental mechanism for regulating interactions
between the holoproteins (or their cleaved ectodomains) with
other membrane-associated signaling complexes involved in
neuronal growth, synaptic plasticity, and injury responses (Kogel
et al., 2012; Wentzell et al., 2012; Milosch et al., 2014).
With respect to our analysis of APPL processing in insect
neurons, it is noteworthy that we obtained virtually identical
results by immunolabeling endogenously expressed APPL or by
expressing fluorescently tagged APPL (or APP695) under the
control of the endogenous Appl promoter. This congruency
gives us increased confidence that we have identified authentic
patterns of APP trafficking and processing in healthy neurons,
a point that has been contentious in past studies (Muresan
and Ladescu Muresan, 2015; Niederst et al., 2015). In addition,
we obtained similar patterns of immunolabeling using multiple
fixation protocols and antibodies against each domain of APPL
(as indicated in Figure 1A), providing further evidence that the
subcellular distributions that we reported for different cleavage
fragments were not simply the result of epitope masking. In
addition, all of our N-terminal APPL antibodies (but not C-
terminal antibodies) strongly labeled hemocyte macrophages in
Manduca that surveil the developing nervous system (Figures 3,
6, “m”). In unpublished studies, we used a variety of methods to
show that these macrophages do not themselves express APPL
but rather actively phagocytose soluble sAPPL ectodomains both
in vitro and in vivo. Based on other evidence that APP/APPL
fragments can induce both neuroprotective and neurotoxic
responses (Wentzell et al., 2012; Milosch et al., 2014), we
postulate that the sequestration of sAPPL fragments by nearby
macrophages may protect the developing nervous system from
these bioactive cleavage products. Likewise, we detected a distinct
population of smaller cells within the developing CNS of
Manduca that labeled with anti-nAPPL but not anti-cAPPL
(Figure 6, yellow arrows). The position and morphology of these
cells suggest that they might represent one of the astrocyte-like
glial populations identified in insects (Meyer et al., 1987; Oland
et al., 1999; Edwards and Meinertzhagen, 2010; Freeman, 2015),
which (like the peripheral macrophages) may scavenge sAPPL
fragments released by neighboring neurons. Alternatively, they
might comprise a distinct neuronal subtype that preferentially
accumulates nAPPL cleavage products within their somata,
similar to our observations inDrosophila (Figure 13). Additional
studies combining glial-specific markers with our sAPPL uptake
assays should help resolve this issue.
Another unexpected finding revealed by our experiments
using double-tagged APPL and APP695 constructs is that
different neuronal populations within the CNS processed the
holoproteins in remarkably different patterns. When we induced
the expression of these constructs with pan-neuronal drivers
(Appl-GAL4 or elav-GAL4), we found that some neurons
maintained robust levels of the holoprotein, while others
preferentially accumulated either N- or C-terminal fragments
in their somata (Figure 12). Particularly striking were the
diverse patterns of APPL processing that we observed when
we expressed the double-tagged proteins in specific subsets
of CNS neurons: even within neuronal groups sharing the
same transmitter phenotype, we found surprisingly variable
distributions of the holoproteins vs. N- and C-terminal fragments
in their cell bodies and processes (Figure 13). These observations
reveal unexpected complexity in the manner by which different
types of neurons regulate the expression and distribution of
APP family proteins. These results are also reminiscent of a
previous study in Drosophila, which revealed the preferential
accumulation of different APPL cleavage fragments within
neuropil regions targeted by specific neuronal populations
(Torroja et al., 1996). We postulate that our results reflect cell-
specific differences in the roles that APP family proteins may
serve in both the embryonic and mature nervous system (Nicolas
and Hassan, 2014; Nhan et al., 2015; van der Kant and Goldstein,
2015).
Lastly, our experiments in the developing ENS of Manduca
support the model that APP family proteins can function as Goα-
coupled receptors under both developmental and pathological
conditions (Nishimoto et al., 1993; Okamoto et al., 1996;
Niikura et al., 2004). In previous work, we demonstrated that
hyperactivation of APPL-Goα signaling induced local retraction
and stalling by the migratory EP cells (Ramaker et al., 2013). We
also have now shown that this response is normally regulated by
Manduca Contactin, which is expressed by glial populations that
ensheath the EP cells and acts as a functional ligand for APPL
(Ramaker et al., 2016). Our current studies have now shown
that treating the EP cells with α-secretase inhibitors caused
both a marked increase in membrane-associated APPL and a
significant inhibition of migration and outgrowth (Figure 8),
recapitulating the effects of hyperstimulating APPL or Goα
signaling in the developing ENS (Horgan and Copenhaver, 1998;
Ramaker et al., 2016). By comparison, neither β- nor γ-secretase
inhibitors significantly altered membrane levels of APPL or
affectedmigration, although they did affect other aspects of APPL
processing (as described above). Given that α-secretases might
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target other neuronal receptors that affect the motile behavior of
the EP cells (Seals and Courtneidge, 2003; Blobel, 2005; Kuijper
et al., 2007), additional experiments will be needed to test whether
these effects are specifically due to elevated levels of APPL in
their leading processes. Nevertheless, our results suggest that
the dynamic regulation of APPL trafficking and processing in
the developing insect nervous system plays a critical role in
modulating neuronal behaviors mediated by the holoprotein
(and possibly its cleavage fragments), providing a new perspective
on how APP family proteins might contribute to a wide variety
of cell type-specific responses within the embryonic and adult
nervous system.
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